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TREATMENT IN SAUDI ARABIA AS PERCEIVED BY THE PATIENT 
ABSTRACT 
Saudi Arabia, one of the developing countries, has a 
number of problems with the health care and medical treat-
ment of the Saudi people. This study was undertaken to 
identify and to examine some of these problems and the role 
of the pharmacist in health education. 
A questionnaire was developed and sent to 200 Saudi 
-----~~-----s-t--u.-deiTt-s--±-rT--tlTe-Urrrt-e-a---st-a t-es-; -11-1--- c-omp-l-ete-d qu-est-ionnaires ----------- ----
were returned. The questionnaire was also sent to Saudi 
Arabia where 51 persons were interviewed. Results of the 
questionnaire indicated that some of the problems identified 
were due to the attitudes of the person interviewed and others 
resulted from the quality of pharmaceutical services which 
were provided. Some patients in Saudi Arabia want a "cure" 
from the first contact with the physician; some do not want 
to use the medications for a long period of time, for example, 
those who are undergoing treatment for chronic diseases. 
Some go to more than one physician and may receive pres-
criptions for two or more drugs. Others may discontinue 
the drug and not return to the physician. Some may obtain 
their medications without a prescription and others may 
use the medication(s) prescribed for other persons. Gen-
erally, it was determined that the services provided by the 
pharmacist were not what the patient expected and wanted. 
Also poor communication between the patient and the pharma-
cist was identified. Language problems were the usual 
cause cited. 
These problems may lead to treatment failure and/or 
an increase in the incidence of adverse drug reactions or 
drug-drug interactions. 
Recommendations were developed in an attempt to allevi-
ate some of these problems. These recommendations include 
the requirement that each hospital keep a medical record 
for each patient, and also that a medication record for each 
patient be kept in the pharmacy to avoid the duplication o 
medications (prescriptions). The law or regulations which 
restricts the availability of medicines without a prescrip-
tion from any pharmacy inside the hospitals or from market 
pharmacies should be adhered to and enforced by the 
pharmacists. 
-,, 
Appointments for outpatients should be made to reduce 
the crowds of people at the doctor's office or at the pharmacy 
windows. This will encourage good communication and allow more 
time for the physician, pharmacist and the patient to discuss 
the disease and treatment. To overcome poor communications 
due to the language barrier, it is important that only those 
physicians and pharmacists who can speak the Arabic language 
work in the outpatient departments. 
Encouragement of patient participation in his treatment 
can be provided by enhancing health education in the media 
such as in newspapers and on radio and television programs. 
The pharmacist should play a role in solving these problems 
b-Y-mG n-i-tG-r-i-n-g--<1-Fu-g-t-h-er-a-py--.-- --------- -------
The appendix contains a proposal which specifies the 
types of information which should be provided to Saudi 
patients regarding their prescribed medications. The 
diseases included in the appendix were selected as examples 
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Saudi Arabia has an area of approximately 2,000,000 km2 
and has a population of approximately 7,600,000. There are 
89 hospitals which have 12,000 beds, 299 outpatient health 
centers which are run by physicians and 383 dispensaries 
which are run by auxiliaries. There are approximately 
4700 physicians,8% of whom are Saudi and 6400 nurses, 14% 
of whom are Saudi (1). 
Saudi Arabia has specialized hospitals which have soph-
~sticated equipment and well trained staff. The services 
in these hospitals are excellent. They are controlled by 
different departments of the government, such, as the Ministry 
of Health, Defense, Interior, the National Guard, and the 
University (2). There are three types of services avail-
able especially in villages and rural areas. The first 
type: which is called Type A, has two physicians and several 
nurses and unskilled personnel. The second is Type B which 
has one physician and one nurse, and the third is Type C 
(Health Point) which is staffed by a nurse or a pharmacist 
assistant and one servant. All hospitals have large 
outpatient departments (2). 
1 
2 
A weekly television program, called "Medicine and 
Life" is run on five stations in Saudi Arabia (3). It re-
quests the viewers to send letters asking about health prob-
lems which the program could explain or upon which they could 
give advice. Five thousand two hundred forty letters were 
received during the past five years and 786 randomly selec-
ted letters were analyzed. Six hundred four letters asked 
s-pec-i-f-i-c-a-1-1-~,...-a-bo-u-t-t-he-w"ri-t-ers-'- own---i-l-l-nesses-;---- --T-he--ma-j-or 
problems that the viewers mentioned in the letters are 
listed in Table 1. Another report (4) included a list of 
primary care problems, and involved' the first 166 patients 
who attended the outpatient clinic in the Riyadh Military 
Hospital (between 9 October and 20 October, 1978). The 
166 patients presented, had 240 medical problems (incidence 
1.4 problems per patient) and Table 2 lists the problems in 
descending order of incidence. 
Saudi Arabia, one of the developing countries, has 
problems concerning health care and treatment of diseases. 
These problems can be summarized as follows: Many patients 
want a cure from the first contact with the physician; some 
do not want to use the medications for a long period of 
time; the patient may change his doctor and may receive two 
prescriptions; and the patient may stop or discontinue his 
medications without returning to the doctor. The person may 
use medications obtained from friends or relatives, or may 
go directly to the pharmacy to get his medications without 
a prescription and without realizing the potential hazards 
3 
Table 1. The 15 Main Health Problems Mentioned by 
Correspondents to the Television Program 
(Medicine and Life) (3). 
Problems Male 
Infective and parasitic diseases 22 
Neoplasm 






Disease of nervous system 
Disease of circulatory system 
Disease of digestive system 
Disease of ~espiratory system 
Disease of genito-urinary 
system 
Complications of pregnancy 
Disease of niusculo-skeletal 
and connective tissue 
Disease of skin 
Congenital anomalies 















































Table 2. Occurrence of 240 Medical Problems in 166 Patients 
seen at the Out Patient Department, Riyadh 
Military Hospital (4). 
Problem No. of Problems Percentage 
Gastrointestinal 51 21.3 
Cardiovascular 49 20.4 
Dermatological 33 13.8 
----~---Re_sp_ir_at_o_r_y, ___ --------~---------29 ________________ 12_._1_____ _ ______ _ 
Genito-urinary 19 7.9 
Neuropsychiatric 18 7.5 
Musculo-skeletal 14 5.8 
Endocrine 10 4.2 
Obstetric 8 3.3 
Iatrogenic 5 2.1 
General debility 4 1. 7. 0 
of self medication. Communication between the physician 
and the patient is frequently inadequate, and communica-
tion between the pharmacist and the patient is usually 
poor. 
In Saudi Arabia, the patient frequently goes from one 
clinic 'to another and from one physician to another. Patients 
can buy non-narcotic analgesics and tranquilizers without 
-------a-presc!'-ip-tion_, __ _ 
The Dean of the School of Pharmacy at the University 
of Riyadh has stated: 
" ... like many other developing countries, several 
factors contributed to the less than optimal use 
of drugs in Saudi Arabia. Some of these contrib-
uting factors were unawareness among the public 
about the danger involved in self medication, poor 
patient compliance, the availability of most of 
the non-narcotic drugs without a prescription, a 
lack of adequate drug information, poor physician-
patient-pharmacist communication, and the promo-
tional activities of drug companies." (5) 
A study was conducted by Dr. Al Sebai (1) of three 
health centers in rural areas of Saudi Arabia. These centers 
did not differ from those in other parts of the country, 
especially the out-clinic patient departments of general 
public hospitals. This study showed that the physician 
spent approximately three minutes with the patient due to 
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the large number of people and lack of physicians. This 
time did not allow the physician the opportunity to diagnose 
or to treat the condition properly. This study also showed 
that diagnosis was based upon clinical impressions without 
any diagnostic facilities. Medications were sometimes dis-
pensed indiscriminately. Sixteen patients were interviewed 
after they had been discharged from the outpatient department. 
ness, and only five patients of the sixteen knew how to 
use the medication prescribed for them. This study showed 
that 30% of all prescriptions were for antibiotics and 18% 
of these antibiotics were chloramphenicol.· Injections of 
chloramphenicol were given to the children. Twenty-four per-
cent of the prescriptions were antipyretics and analgesics. 
The author concluded that antibiotics were used indiscrim-
inately. For example, patients may receive one injection 
of an antibiotic and then enough oral doses for three days 
of treatment, which he o.r she may not use. From the above, 
it was clear that the patients in these centers failed to 
absorb the information which was given to them. The study 
concluded that these centers did not perform their function in 
an adequate manner due to several factors or reasons. The 
reasons given were (1) lack of physicians' understanding 
of their role, (2) shortage and inappropriate distri-
bution of Saudi physicians, and (3) inadequate planning, 
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supervision, and follow-up of the function. This study 
concluded that the main problem was the lack of health 
education in the people served, which resulted in poor 
community participation. 
The patient in Saudi Arabia needs more information 
about health matters and more effort and time must be spent 
in health education. In studies comparing the primary 
e-a-r-e-s-:>t-s-t-em-(-f-i-P-s-t-een-t-a-e-t-)---a-n d--f-i-r-s-t- -1-e v-el -p-r i-ma-X-J1 --G a!!-e-, 
Dodd (6) presented several illustrative cases. The cases 
demonstrated some patients' reactions to and opinions of 
their problems. 
Case I: 
"A middle-aged Sergeant in the Army who had burn-
ing epigastric pain for fifteen years. The pain 
interferes with his life and makes him miserable; 
it has been investigated with several barium meals 
and much treated. He says that it is brought on by 
eating large, fatty meals or hot spicy food and that 
it is not too bad when he takes antacid. When it 
was suggested that he might avoid his pain by modify-
ing his diet, he rejected it because he did not want 
always to be taking medicine. He just wanted a 
straight-forward, once and for all cure of his pain." 
Case II: 
"A Captain in the Air Force, both he and his wife 
have had asthma for four years. About three years 
8 
ago he was given, by a doctor in the town, Betametha-
~one tablets, which produced a very remarkable cure. 
He continued to buy them in the market even after they 
had lost their anti-asthmatic effect and made him obese, 
hypertensive, and cushingoid. He was sent to London 
where his asthma was controlled and he was weaned off 
his steroids. He came home feeling much better and in 
f--ae-t----,-----Se-l-:i:-e-ve€1.--t-ha t-he vvas cured-.- -He --was --ver-y- u-pset--w-hen-------------
the asthma recurred six months later. He came to the 
clinic to see if we could cure him." 
Case III: 
"A man aged about 60, who has had diabetes for about 
four years. At present there is no sign of complica-
tions. His principle symptoms are polyuria and occa-
sional burning micturition. He has attended two pri-
vate doctors in the town, each of whom has prescribed 
a different hypoglycemic agent. According to his 
symptoms each day he takes one or the other, both or 
none of his tablets." 
These cases indicate that patients have a poor know-
ledge of their diseases. From the above cases one can under-
stand the feelings and reactions of uneducated patients 
about their diseases and treatments. 
1. The patient does not realize the danger of the 
9 
illness or disorder, unless it is very severe and leads'to 
hospitalization. 
2. The patient wants a cure from the first contact 
with the physician. He thinks that just one visit is suf-
ficient. 
3. The patient does not want to use the medications 
for long periods of time in chronic disease states;. 
-4-.-He-G-r-s-h-e-de e s-ne-t---r-eco g-n-i ze -t-h-e-- Bene f-i-t-s--- a-nd 
·limitations of the medications. 
5. The patient may discontinue his medications sud-
denly without returning to the physician. 
6. He does not realize the dangers of medication. 
He may misuse or abuse these medications and experience dan-
gerous adverse drug reactions. 
7. The patient may go to more than one physician for 
the same illness and receive different prescriptions. He 
may use both of these prescriptions or just one or none of 
them. 
Another study (7) was done in a Riyadh ~ilitary hospital 
of 10 women between age 21-32 years. They were asked why 
they did not attend antenatal clinics. The reasons given 
for the failure of the women to participate included: fear 
of the doctor; they did not know what the clinic was for; 
or they were feeling well and did not need to visit the 
clinic. When they were asked about the importance of 
attending the antenatal clinic, all the responses were 
"we do not understand the importance of these clinics." 
10 
Five thousand two hundred and forty letters were re-
ceived in the television program (3) and 786 randomly selec-
ted letters were analyzed. Sixty-one percent of the cor-
respondents were male ranging in age from 15 to 25 years. 
Six hundred four letters asked specifically about the cor-
respondents' own illness. One hundred forty-six letters 
out of 786 asked about general health problems. Two hund-
red forty letters which were received included questions 
about a specific treatment for the correspondents' complaints. 
Three hundred sixty letters mentioned the fact that the writer 
had already sought medical advice. One hundred thirty-two 
of the 786 mentioned that they had been seen by more than 
one physician. Thirty-two letters explained that they had 
visited a traditional healer who practiced Arabic medicine. 
This study concluded that consulting more than one physician 
at the same time is a common practice, and the majority who 
wrote these letters were young people interested in their . 
own health. The author recommended further health education 
programs and the introduction ·of these programs into the 
schools (3). 
The pharmacist can have an active role in improving the 
health care in Saudi Arabia. He can be a source of informa-
tion regarding the appropriate use of medications, and the 
pharmacist could provide educational services for the out-
patient such as: 
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1. The importance of taking medicine as directed. 
2. Appropriate dosage schedule. 
3. Determination of drug(s) already being taken by 
the patient which might interfere with any newly 
prescribed medications. 
4. What drugs, food, or over-the-counter medications 
to avoid while on the newly prescribed therapy (8). 
---Th-e-r-e-aX-e-s-e-V-e-!!-a-1--f-u-n-G!-t-i 0n s---l.:v-h-i ch the- pha-rmacists can 
perform such as: 
1. Obtaining and maintaining a patient data base for 
use in making pharmaceutical decisions affecting 
patient care. 
2. Adivising the patient on OTC drug therapy. 
3. Consulting with physicians about therapeutic 
goals and end points, appropriate drug therapy, 
and product selection. 
4. Consulting with patients about the proper use of 
prescription medications. 
5. Referring the patient to appropriate health care 
personnel on the basis of problem assessment. 
6. Safely dispensing, distributing, and administer-
ing medications to patients. 
7. Identifying manifestations of any drug toxicities 
and taking appropriate action. 
8. Serving as a source of health and drug information 
for the patient. (9) 
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The pharmacist may play a role and influence the selec-
tion of over-the-counter (OTC) medications, and the advice 
concerning the appropriate use of OTC medication is the 
responsibility of the P.harmacist. The pharmacist should 
give an accurate therapeutic consultation (10). 
Statement of Purposes 
'T'he_pur_pose_of_this--S-tudy-was--to-determine_the_t¥-Pes ____ _ 
of and the level of information which should be provided 
to Saudi patients about their prescribed medications, and 
to identify problems concerning the patient's use of 
medications prescribed by outpatient departments. A ques-
tionnaire was designed to elicit the above information. 
This thesis analyzed the resul~obtained from the question-
naire, and from this information makes recommendations re-
garding the role of the pharmacist in health education in 
Saudi Arabia. To address the information deficiencies 
identified in the survey, an appendix was prepared which 
includes examples of some diseases which are common in Saudi 
Arabia. Included for each disease is a description of the 
disease and possible causes, drug treatment, instruction to 
the pharmacist and instruction to be given to the patient 
regarding the medications. 
CHAPTER II 
METHODOLOGY 
A questionnaire (Figure 1) was developed, and sent to 
various cities in different parts of the United States. 
The cities were Stockton, Chico, Redwood City, and 
Sacramento, California; Portland, Oregon; and Washington, 
D.C. These cities were selected because they have a rela-
tively large population of Saudi students. The majority 
of these students are males living temporarily in the 
United States. When they finish their studies, it is 
anticipated that they will return home. A questionnaire 
was developed and sent to 200 Saudi students in the United 
States; 111 completed questionnaires were returned. Ninety-
three students were male and 18 were female. The distribu-
tion of the students who completed the questionnaire was 
as follows: Redwood City, 16; Chico, 16; Sacramento, 16; 
Portland, Oregon, 25; Washington, D.C., 20; and Stockton, 
CA, 18. These students represented different parts of 
Saudi Arabia which included all of the five regional divi-
sions, West~ East, North, South, and the Middle. 
The format of the questionnaire is presented in Figure 
1. It was requested that these questions be answered as 
13 
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to the respondents' behavior and experience in Saudi Arabia 
and not their experience in the United States. The quesion-
naire shown in Figure 1 was also sent for administration 
in Riyadh, Saudi Arabia in order to get responses for com-
parison with the answers given in the United States. Fifty-
one persons (44 males, 7 females) completed the questionnaire. 
The majority of respondents were male because it is difficult 
to get responses from females in the unmixed society which 




These questions relate to our society in Saudi Arabia. 
answer them honestly and relate them'to our society. 
Please 
Name: ----------------------------------------------------------
Age: Sex: Occupation: ------------------- --------------- ----------------
School: 
City in Saudi Arabia that you came from: 
----------------------~--------
1. When do you go to the physician (doctor), or to the hospital? 
a) immediately after you feel sick 
b) wait a while, and then go 
c) only if you feel very sick 
2. Do you always complete the course of medication (drug) which the 
doctor prescribed for you (gave you) according to the directions? 
a) Yes b) No 
3. After you feel better, do you continue to take your treatment (drugs)? 
a) always b) frequently c) sometimes d) never 
4. Do you go to the pharmacy (drug stores) directly to get your 
medication (treatment) without going to the physician? 
a) sometimes b) frequently c) always d) never 
5. Do you use the medications of others (such as friends and relatives) 
if you think your sickness is similar? 
a) always b) sometime.s c) frequently d) never 
6. Do you visit more than one physician (doctor) for the same illness? 
a) sometimes b) always c) never 
7. If you have drugs (medications) from past illnesses (diseases) 
which the doctor gave you, do you use those medications (drugs) 
without going to the doctor? 
a) Yes b) No 
16 
Figure 1. Continued 
8. How would you like the pharmacist to give you information about 
your treatment (medication, drugs)? 
a) written b) orally (verbally) c) both 
9. Do you think the time which the pharmacist spends with you at 
windows of the pharmacy is enough to understand or to ask about 
your medications? 
a) enough b) not enough 
10. What kind of information would you like the pharmacist to give 
you concerning your treatment (your medications)? 
11. Are you satisfied with the services which the pharmacist gives 
you in Saudi Arabia? 
a) Yes b) No 
If you answered NO, please explain: ____________________________ ___ 
CHAPTER III 
RESULTS 
The questionnaire was completed by one hundred elever· 
Saudi students living in the United States and 51 persons 
living in Saudi Arabia. The age and sex distribution of 
~- ~-- ~----- ----- ~~~- -~~ ~~~~--- --- - ---- --- ~-~~- --~--~-~~-- ------~--~ ~--
the respondents living in the United States are given in · 
Table 3, and the age and sex distribution of 51 respondents 
living in Saudi Arabia are given in Table 4. 
The answers of each group are summarized in Table 5 
(United States respondents) and Table 6 (Saudia Arabia 
residents). The answers to question #10 in Figure 1 and 
part of answers to question 11 in Figure 1 were comments 
from the respondents. 
A comparison (Table 7) was made between the answers 
of the que$tionnaire which was administered in Saudi 
Arabia and the one which was sent to the students from 
Saudi Arabia in the United States. This comparison includes 
the percentage of people from 51 Saudi Arabians who answered 
the questions. All of these people were asked the same 
questions (Figure 1) except question No. 7 which was inad-
vertently omitted to Saudi respondents living in Saudi 
Arabia. 
The answers to question #10, Figure 1, "What kind of 
information would you like the pharmacist to give you 
17 
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Table 3. The Age Distribution of Saudi Students in the 
United States Responding to the Questionnaire.* 
Gender Age Range Number 
Males 18-24 43 
25-31 44 
32-38 5 
Over 38 1 
------
Total 93 
Female 18-24 15 
25-31 1 
32-38 1 
Over 38 1 
Total 18 
*The majority of persons answering were males because the 




Table 4. The Age Distribution of the People in Saudi Arabia 
Responding to the Questionnaire.* 
Gender Age Range Number 




Over 38 12 
Total 44 
Female 18-24 3 
25-31 1 
32-38 1 
Over 38 2 
Total 7 
*The majority of persons answering were males because it 
is difficult to get responses from females in the unmixed 
society which exists in Saudi Arabia. 
-
R 
Table 5. The Results of the Questionnaire From 111 Saudi Students in 
the United States. 
Questions 
1. When do you go to the doctor 
or the hospital? 
Males 
a. immediately after feeling sick 26 
b. wait a while, and then go 27 
c. only if they feel very sick 40 
2. Do you always complete medicine 
as prescribed by the doctor? 
a. Yes 
b. No 
3. After you feel better do you con-






4. Do you go to the pharmacy direc-
tly to get medicine without going 





5. Do you use the medications of 
others (i.e. friends, relatives) 
if you think that your sickness 

























































Table 5. Continued 
Questions Males 
6. Do you visit more than one physician 




7. If you have a medicine for a 
past illness (prescribed by a 
doctor) would you use it again 
for the same illness without 
seeing the doctor? 
a. Yes 
b. No 
8. How would you like the pharmacist 





9. Do you think the time the pharmacist 
spends with you at the window is en-
ough to ask or understand about your 
medicine? 
a. Enough 
b. Not Enough 
ll . Are you satisfied with pharmacists 










































Table 6. The Results of the Questionnaire Administered in Saudi 
Arabia out of 51 Surveyed. 
Questions 
1. When do you go to the doctor or 
to the hospital? 
a. immediately after feeling sick 
b. wait awhile, and then go 
c. only if they feel very sick 
2. Do you always complete the course 
of medication which the doctor 




3. After you feel better do you con-




4. Do you go to the pharmacy directly 




5. Do you use the medications of 
others (i.e., friends, relatives) 
if you think that your sickness 








































Table 6. .Continued 
Questions Males 
6. Do you visit more than one physician 
for the same illness? 
a. Yes 
b. No 
8. How would you like the pharmacist 





9. Do you think the time which the 
pharmacist spends with you at 
the windows of the pharmacy is 
enough to understand or to ask 
about your medications? 
a. Enough 
b. Not Enough 
11. Are you satisfied with the pharmacists 
services which the pharmacist gives 
you in Saudi Arabia? 
a. Yes 
b. No 
































Table ]. Comparison of the Answers to the Questionnaires Administered 
in the U.S.A. (111 persons) and Saudi Arabia (51 persons). 
Percentage of 51 Percentage of 111 
respondents in students in the 
Questions Saudi Arabia (No.) United States (No.) 
1. When do you go to the doctor 
or to the hospital? 
-_a_. ___ irnrnedia~ely_after _you_ ---------- -----
feel sick 20% (10) 27% (30) 
b. wait awhile, and then go 4i% (21) 29% (32) 
c. only if you feel very 
sick 39% (20) 44% (49) 
2. Do you always complete your 
medications as prescribed? 
a. Yes 76% (39) 55% (61) 
b. No 24% (12) 45% (SO) 
3. After you feel better do 
you continue to take your 
medication or treatment 
as prescribed? 
a. sometimes --* 43% (48) 
b. frequently --* 20% (22) 
c. alway's (yes) 37% (19) 6% (7) 
d. never (no) 63% (32) 31% (34) 
4. Do you go to the pharmacy 
directly to get your med-
ication (drug) without 
going to the doctor or with-
out a prescription? 
a. sometimes --* 54% (60) 
b. frequently --* 8% (9) 
c. always (yes) 28% (14) 5% (6) 









Saudi Arabia (No.) 
5. Do you use the medications of 
others such as friends or rela-
tives, if you think that your 
sickness is the same? 
a. sometimes 
_'J.,.- .,:; __ ,.,. ........ -_ .... _,_ ...... 
----- -- ------- u-.-J.-.L-~quc11'-.L:/ 
c. always (yes) 
d. never (no) 
6. Do you visit more than one 
physician for the same illness? 
a. sometimes 
b. always (yes) 
c. never (no) 
8. How would you like the pharma-
ci~t to give you information 




9. Do you think the time which the 
pharmacist spends with you at the 
window of the pharmacy is enough 
















11. Are you satisfied with the services 






Percentage of 111 
students in the 
















*These choices were inadvertently omitted from the questionnaires admin-
istered in Saudi Arabia. 
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concerning your treatment?" can be summarized as follows: 
1. How to use the medication correctly. 
2. What the patient should do if there are any 
adverse reactions. 
~ -
3. What the patient should do if he forgets to.take 
Fl--
the medications. 
4. The possible side effects of the medications. 
----------- --5---.-------Hew---lEJng--t-he---d-rug--shou-ld -be llSed--; -a-i1d -ir1f-ol~rnat-ion-- ------- ---
regarding necessity for refill. 
6. The storage of the medications, and the expiration 
date. 
·7. If there are any foods which interfere with the 
treatment. 
8. What the dangers of overdose are and what to do 
if overdose occurs. 
9. Why the doctor gave them a specific drug for 
their illness. 
10. Some information about their illness. 
11. Explanations of all information concerning their 
treatment. 
Question #11, Figure 1, asked, "Are you satisfied with 
the services which the pharmacists give you in Saudi Arabia?" 
Possible answers were "yes" or "no," and if the answer was 
"no," an explanation was requested regarding dissatisfaction 
with the service. The explanations are represented by the 
following: 
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1. Pharmacists do not care about the patients. 
2. Pharmacists are foreigners and they can not 
speak Arabic. 
3. Pharmacists do not give enough information 
to the patient. 
4. Pharmacists do not always give written instruc-
tions concerning the use of the medications. 
5. Limitation of time available with the pharma-
cist due to the crowds of people at the windows 
of the pharmacies. 
6. Writing on the label is handwritten and is dif-
ficult or impossible to read. 
7. The explanations which are given orally do not 
satisfy the patients because they are unable to 




Table 7 shows a comparison between responses from 
Saudi students living in the United States and responses 
from students residing in Saudi Arabia. In response to ques-
tion No. 1, "When do you go to the physician (doctor) or the 
hospital?" the two groups showed a similarity in that a 
large .Percentage of both groups chose the answer "only 
if you feel very sick." This indicates they may not realize 
the dangerous nature of their illness. Question 2 (Table 7) 
asked, "Do you always complete the course of the medication 
which the doctor prescribed for you according to the direc-
tqons?" The answers given by the two groups show that a 
large percentage from both groups may not follow the instruc-
tions which were given and it indicates that this percentage 
is greater among the students living in the United States than 
among the correspondent living in.Saudi Arabia. This indi-
cates that the role of the pharmacist is to inform the patient 
whether he needs to refill the prescription or not, and to 
emphasize that the patient must complete or continue to take 
the medications as prescribed. 
The patient often stops taking the medications at the 
first sign of relief. This is confirmed by the answers 
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to question No. 3 (Table 7) which asked, "After you feel 
better do you continue to take your medication or treatment 
as prescribed?" which indicated that a high percentage of 
both groups never continued to take the medications after 
they felt better. The apparent discrepancy between the 
responses to these two questions may be explained as fol-
lows: Two responses were inadvertently omitted to Saudi 
respondents living in Saudi Arabia. It is possible that 
persons who answered "Never" would have selected one of 
the omitted choices. An alternative explanation is that 
interpretation of the two questions is different. The re-
spondents may have believed that they should have taken the 
medications just until they felt better. The responses 
to question No. 5 (Table 7) which asked, "Do you use the 
~edications of others such as friends or relatives if you 
think that your sickness is the same?" indicated that one 
third of each group may use the medications of friends or 
relatives if they think their sickness is the same. The 
reasons why they would do this are unclear since health care 
is provided without cost. However, this is a frequent oc-
currence which may lead to dangerous complications of illness, 
drug-drug interactions, or adverse drug reactions. The pharma-
cists can improve patient medication compliance by the use 
of the following procedures (11): 
1. Multiple medication consultation 
2. Patient follow-up reminders to reinforce patient's 
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knowledge of proper self-administration techniques. 
3. Advising physician regarding patient medication 
non-compliance. 
4. Medication consultation delivered in the proper 
environment. 
5. Additional information in printed or handwritten 
handouts presented to patient. 
The factors which may lead to drug therapy problems 
in outpatient clinics due to the services which are provided 
to the patient include: 
1. Availability of non-narcotics and tranquilizers 
without a prescription (5) which can lead to misuse 
or abuse of the drugs, or to drug-drug interactions. 
Question No. 4 (Table 7) asked "Do you go to the 
pharmacy directly to get medicine (drugs) without 
going to the doctor (without a prescription)?" The 
answers ind~cated that in both groups,there are some 
who go directly to the pharmacy to get medications 
without a prescription. 
2. Absence of a patient's medical record in the hospital 
or in the pharmacy. Even if the record exists, the 
patient may go to another clinic or hospital and 
because of this, it is difficult to recognize the 
duplication of prescriptions. In answers to ques-
tions No. 6 (Table 7) which asked, "Do you visit 
more than one physician for the same illness?", the 
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responses from the students from Saudi Arabia living 
in the United States indicated that 65 of the 111 
may see another doctor and may receive another 
prescription. They may use the two prescriptions 
together or they may not. Case III (6) in the 
Introduction described a 60 year old man who had 
visited two private doctors; each doctor gave him 
a different hypoglycemic agent and he used both. 
The answers to question Nd. 6 indicated that a sig-
nificant part of the population change their doctor 
quickly concerning the same illness because they 
want an immediate cure from the first visit to the 
doctor, and do not understand either their disease 
or the treatment. 
3. Poor communication between the physician, pharmacists, 
and the patient due to the language barrier and due 
to the limited time which the physician and pharma-
cist spend with the patient. 
Patient compliance can be improved by educating the 
patient, and the most important factor is better communica-
tion between the patient and health care professionals. 
Bal (12) has written about the communication problem of non-
English speaking persons in England. He made several sug-
gestions for physicians to remember when they deal with non-
English speaking patients: talk slowly, simply and clearly; 
repeat words; avoid medical terms; and use logical sequence, 
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illustrations, pictures, and models. He also recommended 
the use of an interpreter if possible. On the other hand, 
in Saudi Arabia the majority of the people speak the Arabic 
' 
language only and it is difficult for them to communicate 
with the physician or pharmacists, or pharmacists assistants 
who cannot speak Arabic. Eliminating the language barrier 
~-~ _may_p_]._a.y____a___S_:i_gnj__f_i_c~nt_r_o_l~ __ in increasing_J2atient_co_mplian_ce--'-- -~-~-- ~~-
Thus, the clinical pharmacist can play an active role in 
determining outpatient problems associated with their therapy. 
A study was done by Christensen, et al. (13) to determine 
the nature and the extent of outpatient drug therapy prob-
lems encountered by the pharmacists. It also described the 
types of drugs which were most frequently involved in these 
problems and the nature of changes in drug therapy problems 
due to pharmacist's intervention. These problems can be sum-
marized as follows: (1) drug overuse, which included a 
wide number of drugs but no specific predominant one; (2) 
drug overuse, with antihypertensives, diuretics, and potassium 
supplements being the most frequently mentioned; (3) drug 
interaction which was classified into two categories, life 
threatening interaction such as phenylbutazone-warfarin, and 
moderate or non-life threatening interactions such as ant-
acids and tetracyclines. The author concluded that there 
were two to four potential drug therapy problems per hundred 
prescriptions dispensed. They demonstrated the importance 
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of pharmacists in decreasing the incidence of these problems. 
The amount of time the patient spends with the physician 
or the pharmacist is very limited because of the crowds of 
people waiting to be served. In reply to question No. 9 -
n--
(Table 7) a high percentage of both groups indicated that 
the pharmacist does not spend enough time at the window ex-
plaining uses of the medications. This factor is caused by 
the large number of people waiting for their medications and the 
very little time the pharmacist assistant or the pharmacist 
has to spend with each patient. The large number of pres-
criptions that are filled may lead to mistakes in the filling 
and little time with the patient to give instructions. The 
answers to question No. 8 (Table 7) which asked "How would 
you like the pharmacist to give you information about your 
medication?" indicate that a high percentage of the U.S. 
respondents would prefer both written and verbal instruc-
tions while the respondents living in Saudi Arabia would pre-
fer written instructions. In reply to question No. 10 (Figure 
1) which asked, "What kind of information would you like the 
pharmacist to give you concerning your treatment?", the 
answers included the desire to know general information about 
the medications such as usage, side effects, adverse reactions, 
foods to avoid, storage, expiration date and specific informa-
tion about the medications dispensed. These responses were 
similar to that which Herxheimer (14) suggested that the 
patient may ask. 
In the reply to question No. 9 (Table 7) which asked 
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"Are you satisfied with the services which the pharmacist 
gives you in Saudi Arabia?" possible answers were "yes" 
or "no," and if "no," an explanation was requested. Ap-
proximately two thirds of each group were not satisfied 
with the services which are provided and the explanations 
were carelessness of the pharmacists, and poor communica-
tion with the pharmacist due to a) the language difference, 
_____________ b_)_l_imi_t_a±_i_o_n __ o_f_time--spent----Wi th----each-- pa-tient-,-- -c)- c-~0\vds------------------
of people waiting and the high level of noise and inability 
to hear what the pharmacist is saying. The written instruc-
tions on the label are handwritten, difficult to read, and 
lack adequate information given by the pharmacist. 
CHAPTER V 
CONCLUSION 
The factors or reasons which usually lead to the in-
________ cl'_ea~~~-~ !~c-~~-n~e <:)_f_ ::1.~""-'erse drl1g reacti_on_s, c!ru~-drug_ 
interactions, and. toxic reactions of medications in Saudi 
Arabia have been discussed. The out-patient in Saudi Arabia 
does not. have a medical record in the outpatient department 
or in the pharmacy. It is important that hospitals and 
pharmacies keep records for the patient in an organized 
manner to avoid the duplication of prescriptions. The 
patient must be encouraged to cooperate with this system. 
Since non-narcotic and tranquilizer drugs may be ob-
tained without a prescription, it is important to follow the 
law or the regulations i.f there are any, and restrict avail-
ability of these medicines from any hospital pharmacy or from 
the market pharmacies without prescriptions. 
There is poor communication between the physician· and 
the patient and between the pharmacist and the patient due 
to the language barrier and the limited time which the physician 
and the pharmacist spend with the patient. The physicians 
and pharmacists who can speak the Arabic language should work 
in outpatient departments, and those who cannot speak Arabic 





the name of a physician and then waits at the physician's 
office door with many other patients until called; this 
causes the physician to be in a hurry and spend less time 
with each patient. An appointment based on a triage system 
is recommended. Well experienced physicians working in the 
admission office could screen and classify the patients de-
pending on the type and severity of illness. An appointment 
should be given to those patients who can wait. Patients 
needing immediate care would be seen by the appropriate 
physician. This will reduce the pressure on the pharmacy 
and will give the patient and the .pharmacist or pharmacist 
assistant time to provide appropriate information and will 
give the patient time ,to ask questions about his illness and 
medications. 
There is a lack of compliance by the patient regarding 
instruction for his treatment. Better patient compliance 
can be obtained by use of appropriate publicity in television, 
radio, newspapers, journals and by the introduction of health 
education as a requirement in the secondary schools. 
The pharmacist should play an active role in helping 
solve these problems by monitoring drug therapy and thus 
preventing adverse drug reactions and interactions. Pharmacists 
can advise patients about possible dietary (food-drug) inter-
actions, or other medical problems which may interfere with 
their treatment. The pharmacist should verbally explain to 
the patient the directions, possible side effects, and the 
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proper storage of medications. The pharmacist should provide 
typed instructions on how .to use the drug, the expiration 
date, the name of the doctor, and the name of the person for 
whom the prescription is being filled. This should be typed 
on the label instead of handwritten and abbreviated. 
Finally, the pharmacist must consider himself an educa-
tor and consultant regarding medications and health related 
problems. He should expand his role in these areas. The 
pharmacist must continue to study, and read journals to 
maintain and improve his information skills. The pharmacist 
should attend continuing education programs or conferences, 
have regular conferences with his colleagues, which will help 
him to be up to date. 
The pharmacist has a unique position to reinforce medica-
tion instructions and make a valuable contribution to the 
durg therapy of each patient, since he is the last person 
which the patient sees. It is important for the patient to 
be given instructions and information by the pharmacist re-
garding the illness and/or treatment. This information should 
be given verbally to those people who cannot read, and in 
printed form explained in simple language for those who can 
read. He can provide printed pamphlets on specific diseases 
or drugs. He could prepare health educational materials for 
.newspapers, television, radio to educate the public about 
medications and their appropriate use. 
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A proposal regarding the nature and level of information 
which pharmacists should provide to Saudi patients on their 
prescribed medications is presented in the appendix. This 
appendix does not represent all of the diseases which are 
common in Saudi Arabia, but contains examples of some 
classes of diseases which are mentioned in the introduction. 
The information given for each disease can be used as a source 
for additional labeling to provide more specific administra-
tion details, and to encourage the patient to participate in 
his treatment. It can also be used as a source of informa-
tion for patient education or for handouts which can be 
given to the patient. 
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In a general public hospital or outpatient department, 
the factors usually leading to the treatment-failure, in-
creased incidence of adverse drug reactions and harmful 
--- -d-:rug-in-terae-t-:i:0ns-,-and--toxici ty of medi-cation are the follow-----
ing: First, the patient rarely has a record in the hospital 
or pharmacy; even if a medical record exists in a particular 
hospital, the patient may go to another facility, making 
the recognition of overlap or the duplication of prescrip-
tions extremely difficult. Second, the availability of non-
narcotics and tranquilizers without a prescription contri-
butes to the misuse or abuse of a drug, or to adverse drug 
reactions. Third, the communication between physician or 
pharmacist and the patient is usually very poor due to the 
difference in language and background and the insufficient 
amount of time devoted to each patient. 
A questionnaire was developed and sent to Saudi students 
in the United States and a sample in Saudi Arabia asking 
them what they would like to know, in general, about diseases 
and their treatment. Their responses influenced the type 
of information given for each of the selected diseases in 
this appendix. The ensuing body of information is neither 
meant to be a comprehensive catalog of all diseases found in 
Saudi Arabia, nor a replacement for the physician, but rather 
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a proposal and aid to increase the awareness of the people 
and to help the pharmacist or pharmacist assistant under-
stand what the patient needs to know. The aim of this paper 
is to look briefly at each of· eleven diseases and con-
ditions, focusing on the identification and methods of con-
trol of these diseases, instructions for the patient, the 
role of the pharmacist both to help in public health educa-
-------------t-ie-n----o-f--t-hese and- ot-her- medical problems, as ---wel-1-- -as --to -hel-p-----------
decrease the incidence and improve the treatment of the 
selected diseases. 
The first two chapters deal with two parasitic diseases 
common in Saudi Arabi, Giardiasis is common in Saudi Arabia 
because of several factors: First, the climate of Saudi 
Arabia is hot and very suitable for parasites. Second, there 
are some customs, especially hand-shaking, because of infre-
quent hand washing, which aid in the transmission of this 
disease. Third, most of th~ population eats by hand and often 
people, especially children, do not wash their hands before 
eating, leading to the increase in the incidence of Giardiasis 
especially with children. Finally, Saudi Arabia is an 
underdeveloped country. The majority of the population is 
ot educated and poor sanitation exists almost everywhere. 
-The second chapter deals with amebiasis. Amebic dysen-
tery is probably the most important tropical infection present 
in the Middle East, found in a large percentage of the popula-
tion. There are several factors which contribute to this 
high percentage. First, the climate is hot and suitable 
---------
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for parasites. Second, this infection is endemic in this 
area. Finally, the large population of flies contributes 
to the transmission of this infection. Generally, the most 
important promoting factor is the inadequacy of health 
education to enable the people to prevent this disease. 
The third chapter discusses trachoma, a major problem 
in Saudi Arabia. It is worldwide in distribution but it 
----- -------- ---------- ------
is endemic in the Middle East. The high prevalence is due 
to the poor hygiene of people, the crowded living conditions, 
and the dusty windy weather. 
Sexually transmitted diseases are the topic of chapter 
four. They are worldwide, as well, and not usually reported 
in Saudi Arabia because the patient does not often go to a 
physician. The refusal to report these diseases is a major 
problem. The reason that sexually transmitted diseases are 
included in this section is to help young people and others 
take care of these infections themselves and to help increase 
their awareness of their hidden problems. 
The fifth chapter focuses on peptic ulcer, the inci-
dence of which is increasing rapidly due to changes in the 
way of life and the daily living habits of the people. 
There is increasing evidence of smoking and an increase in 
stress. There are many commonly used drugs which may induce 
ulcers such as aspirin and phenylbutazone. 
Chapter six is concerned with iron deficiency anemia, 
common, particularly in children, due to malnutrition or 
an unbalanced diet. The incidence is also common in women 
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because of frequent pregnancies and iron deficient diets. 
The sev~nth chapter deals with rheumatoid arthritis. 
This disease was selected because of the difficulties of its 
management, the increase in the incidence of drug-drug 
interactions and the frequency of self-treatment. 
Chapter eight, concerning adult onset diabetes mellitus, 
discusses this disease, and the symptoms and methods of 
-- -- -- ------moni tor1ng fl:ie- c6ri.dT f ron-~-- ---
Hypertension in chapter nine is another important 
factor, along with diabetes, in causing heart problems and 
cerebral vascular accidnet, in Saudi Arabia. 
Chapter ten discusses epilepsy, about which there are 
some misconceptions heightening the chances for several 
problems, such as uncontrolled seizures due to failure of 
the treatment, drug interactions which interfere with the 
treatment or adverse reactions from the treatment. 
The Appendix concludes with glaucoma, which is common 
in elderly people. It is considered the first cause of 
blindness and hence frustration for many people. 
The role of the pharmacist for outclinic patients 
includes consultation concerning the nature ~nd symptoms of 
the disease, and the nature of the medications used in'the 
treatment of the disease. In an attempt to achieve a 
balance of information for each disease, each chapter 
includes the following information: 
1. A description of the disease and possible cause; 
2. Drug treatment, usual drugs and dosage; 
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3. Instructions to the pharmacist for each disease 
and on his role in their treatment; and 
4. Instructions to be given to the patient 
regarding the medication, and for infectious 
----
~ 




Giardiasis is an infection by the parasite called 
Giaradia lamblia. This parasite is from the family Hexa-
mitidea. Motile giardia averages about 7 x 14 Mm and has 
two nuclei and four pairs of flagella and has a specific 
characteristic which is a suction disc on its ventral 
surface. The two stages of this parasite are (1) the tropho-
zoite which cannot live outside the body, an~ (2) the 
pathogenic cyst form which exist. as pairs (1). The hosts 
are mainly man, pigs, and monkeys (2). The mode of trans-
mission is contaminated water, food and from one person to 
another. In Saudi Arabia flies play a major role in the 
transmission of this disease. The usual incubation period 
is 15 days and the average duration of symptoms is 44 days 
(1). This parasite lives in the duodenum and upper part 
of the jejunum. The disease can be symptomatic. The symp-
toms of long duration are diarrhea and accompanying weight 
loss from dehydration, and abdominal pain. The stool is 
watery and odiferous and sometimes the stool·is accompanied 
by mucous. The disease interferes with intestinal functions 
resulting in malabsorption of fat, vitamin A, glucose, 
xylose, folic acid, and vitamin B12 (which can cause other 





This infection is most common in children, is the first 
cause of steatorrhea and it mimes celiac disease (intestinal 
malabsorption characterized by diarrhea, malnutrition, 
bleeding tendency, and hypocalcemia) (4). The diagnosis can 
be confused with some kinds of allergies, such as milk 
proteins. 
Occurrence of this disease is worldwide, but it is more 
common in areas with warm climate and poor sanitation. The 
susceptibility of the individual varies from one person to 
another and depends on many factors such as age (the occur-
rence more common in the elderly and children than in young 
adults). Gastroectomy,. decreased gastric secretion, chronic 
pancreatitis, and malnutrition enhance the susceptibility 
of individuals (4). 
The methods of control to prevent this infection are 
numerous. In general, the first thing is the health educa-
. tion of the people in order to increase the awareness about 
this disease. Second, the disposal of feces must be in a 
suitable place, far away from the public water supply and 
sewage systems should be improved. Third, there should be 
portection by chlorination of the public water supply from 
contamination. Fourth, victims and carriers (who work as 
food handlers in restaurants and food markets especially), 
must be educated regarding this infection. However, there 
is no isolation, quarantine or vaccination for this disease 
(6), and finally, the containment of flies, both by insecti-
cide and sanitary measures, should constitute a major effort. 
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Treatment: The treatment of giardiasis infection 
depends on accurate diagnosis. The diagnosis of this infec-
tion is very difficult and it is based on the microscopic 
scanning for the cyst in the sample of feces, duodenum fluid, 
and jejunum fluid. Also, by the biopsy of intestine and 
looking for trophozoite in the second stage (6). Quinacrine 
hydrochloride (Atabrine) is usually the drug of first choice. 
The usual adult dose is 100 mg, three times daily for seven 
days. The dose for a child is 7 mgjkg of the body weight. 
An alternative drug, metronidazole (Flagyl), is given 2 gm 
daily for 3 days for an adult, 1 g daily for children above 
7 years, 600 mg daily for children 3 to 7 years, and 400 mg 
daily for an infant. Some points should be discussed regard-
ing these two drugs for the treatment of giardiasis. First, 
quinacrine hydrochloride is a very toxic drug, the effects 
of which include dizziness, headaches, mild gastrointestinal 
disturbance, chronic dermatitis, yellow discoloration of the 
skin after prolonged duration of use. Second, the toxicity 
of quinacrine is very dangerous and the treatment is as 
follows: If the patient needs respiration assistance, give 
oxygen, and intravenous fluid, and a vasopressor for hypo-
tension. In acute toxicity, emesis or .aspiration is recom-
mended. The antidote is ammonium chloride which is admin-
istered at 12 gm daily by mouth for the purpose of enhancing 
urinary excretion (8). Finally, metronidazole (Flagyl) has 
toxic effects, but less severe than quinacrine. The side 
effects are gastrointestinal disturbance, anorexia, nausea, 
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vomiting, coated tongue, and darkening of the urine (8). 
Metronidazole (Flagyl) is used with caution in pregnant 
women because there are reports it may cause cancer and thus 
is not recommended during the first trimester of pregnancy. 
Also, metronidazole should not be given with alcohol because 
it interferes with the metabolism of alcohol and produces a 
disulfiram-like reaction. Finally, metronidazole should not 
be used in patients with blood dyscriasis. 
































In conclusion, the best way to prevent this disease is 
education of the people to control, prevent transmission, 
and to help eradicate this disease. 
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How to Prevent Infection from Giardiasis: 
l. Work toward the containment of flies inside the 
house. 
2. Cover food and water to protect them from flies. 
3. Wash with water all fruits and vegetables before 
eating them. 
4. Do not drink standing rain water. 
5. Use chlorinated water if possible, or boil the 
water. 
6. Wash hands before and after eating. 
7. If one person in your family is infected, go 
with him to the hospital and begin treatment. 
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There is some information which the pharmacist should 
tell the patient about the disease and the treatment: 
Instructions to the Pharmacist 
1. Be sure to give the patient the right directions on how 
to use the drug. 
2. Give the patient some information about the drug. 
3. Tell the patient "Do not drink alcohol." 
4. Tell the patient "There is some change in urine color. 
5. Tell the patient to complete the course and return to 
the hospital again. 
6. Give the patient the directions on how to store the 
medication including keeping the medication away from 
children. 
Instructions to the Patient 
1. Your m~dication (Flagyl) can undergo drug interaction 
with alcohol, so there is some problem regarding the 
intake of alcohol with this drug. 
2. Be sure to mention your medication to the other physi-
cians or a lab manager who might want to take or to 
measure thyroid function, as the Flagyl will interfere 
with this. 
3. There will be changes in the color of your urine. 
4. Be sure there is no doubling of dosage and mention the 
name of your medication to any other physician you visit. 
5. Return to the hospital after completing the course of 
treatment; you may need another course of treatment. 
6. If you are a mother do not be confused between the 
diarrhea resulting from the allergies from milk and this 
disease. Go to the hospital if a child has diarrhea. 
Chapter 2 
AMEBIASIS 
Amebic dysentery is probably the most important tropi-
cal infection present in all of the Middle East. This 
infection is common in a large percentage of the population. 
There are several factors which contribute to this high 
percentage. First, the climate o~ Saudi Arabia is suitable 
for this parasite to live. Also, the large population of 
flies contributes to transmitting this infection. Second, 
this infection is considered an epidemic in this area. Saudi 
Arabia now is one of the developing countries where medical 
care is poor and the hygiene is sometimes very poor. 
Finally, the most important factor is that the health edu-
cation is insufficient to educate the people to prevent 
this disease. This chapter will brtefly discuss this 
infection and its treatment, in hopes that it will help 
people pay some attention to this infection, to help the 
reader at least to consider this infection as a major prob-
lem, and perhaps eventually eliminate it. 
The prevalence of amebiasis ranges from 5% in most 
countries to 80% in countries with poor hygiene, especially 
tropical and subtropical countries (9, 10). The parasite 
causing the infection is called Entamoeba histolytica. This 
parasite is mobile and has two stages cyst and trophozoite. 
The trophozoite ranges from 10-60 vm, and usually is 25 vm 
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in length. Also, the trophozoite has a nucleus which appears 
as a halo or a ring under the microscope. The cytoplasm 
consists of granules, food vacuoles, and red blood cells 
which the parasite has ingested. The pathogenic stage is 
the cysts which are able to survive outside a human body, 
in contrast to the trophozoite which can only survive a 
short period of time outside the human body (11). Not being 
acid resistant, the trophozoite is not contagious. The cysts 
are acid resistant and can stay in the soil, ~ater or other 
fomites a long period of time (10). The mode of transmis-
sion for this disease depends on the mechanical transmission 
of the cysts. ·rn Saudi Arabia, flies are considered the 
major mode of transmission. Food contamination by cysts 
or water contamination, plays a role in the transmission of 
pathogenic cysts (11). Roaches can also carry the cysts 
on their legs from feces to food or water and contribute to 
spreading the disease. Also, the cysts can spread from one 
person to another by unclean hands. This mode of spreading, 
especially with food handlers and food stores, is a major 
concern. 
When a person ingests the cysts from one of the above 
sources it causes infection, but if the person ingests the 
trophozoite it is destroyed by gastric acid. The major 
problem is the asymptomatic infections in the carriers as 
this person is the active source of the infection (10). The 
pathogenesis of infection begins when the person ingests 
the cysts which are then converted to immature ameba going 
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into the large intestine. The immature ameba begins to 
invade the mucosa by secretion of alytic substance, and 
causes ulceration, from which the symptoms appear (10). 
Entamoeba histolytica is not always pathogenic but some-
times can become pathogenic and cause serious disease under 
specific conditions: changing diet, increased cholesterol, 
change in hormones, patient under heat stress, and 
increased humidity. All of these stimulate or contribute 
toward changing the non-pathogens to pathogens. The symp-
toms of the disease are different from one disease state to 
another. The acute form is different from the chronic. 
Acute infection occurs after a large dose is ingested and is 
characterized by diarrhea with blood and pus present, the 
infection responded to treatment and is not serious if treated 
effectively. By contrast, the chronic illness is charac-
terized by mild diarrhea with episodes of constipation. 
A complication of the infection is anemia, it resulting 
from the loss of blood over a sustained period of time. 
This anemia is iron deficiency anemia and can be corrected 
by eating foods rich in iron, or an iron supplement (9). 
Another dangerous complication is abscesses of the liver. 
A recent study (14) showed some evidence that the abscesses 
of the liver were due to Entamoeba histolytica infection. 
Another possible complication is amebic pericarditis, which 
is rare (14, 15). 
The usual host is man. Transmission occurs through 
the shedding of cysts in the feces with subsequent 
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contamination of food and water. The usual incubation 
period is two to four weeks, but the incubation period may 
vary from only a few days to as long as several months. 
There is no immunization against this parasite; but it is 
not contagious and thus the patient need not be quarantined. 
Amebiasis can be diagnosed ·in several ways. First, the 
diagnosis could depend on the microscopic examination of 
different samples of feces, looking for cysts or tropho-
zoites. With acute infection, trophozoites are found in the 
feces. Also, stool specimens must be examined immediately 
because trophozoites are destroyed by heat after a short 
period of teim. Second, an indirect hemaglutination test 
on serum specimens could be administered (21). Third, one 
could use an antibody test. This tests depends on the 
indirect--immunoflorescence test (IFT) for the serologic 
diagnosis of amebiasis. It is uncomplicated to administer; 
a few parasites need be present for diagnosis. It is good 
for identifying both acute and chronic infections (16). The 
fourth method of diagnosis is a liver scan for hepatic 
amebic abscesses. 
Another method of diagnosis is proctoscopy and obtain-
ing a sample and identifying ulceration. The parasite may 
be isolated by being cultured in a suitable medium. Any 
one of the above methods is not enough alone to give an 
accurate diagnosis of the illness, as there are different 
species of amebic infection and other easily confused similar 
infections, such as shigellosis, appendicitis, diverticulitts, 
and giardiasis. 
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The methods of control and prevention of the infection 
depend on personal hygiene. Some general principles to 
limit the spread of the infection are listed below. 
1. The living environment inside the cities and vil-
lages must be made more sanitary. 
2. Human feces must be disposed of in a sanitary way 
and covered. 
3. The government is responsible for the protection 
of the public water supply, for using chlorine, 
iodine or sand filter· to remove or destroy the 
infectious cysts. 
4. Education is the best way to control the infection 
by increasing the awareness of the people in regard 
to hygiene and sanitatioti. 
5. Eradication or diminution of the disease would be 
a major step to prevent transmission. 
6. The Department of Public Health must investigate 
the restaurant workers and food handlers, and 
enforce standards of cleanliness. 
On the personal level there are many methods to prevent 
the disease. 
1. Hand.washing after using the toilet, with hot 
water and soap. 
2. Cover your food and your water to protect from the 
flies. 
3. Use a suitable chemical to control the flies while 
using covering or screening on the windows and doors. 
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4. Remove the garbage every day. 
5. Do not eat v~getables or fruit unless they are 
washed with chlorinated water. 
6. Do not eat in restaurants where you are not sure 
about standards of cleanliness. 
7. Wash your hands before eating any kind of food. 
8. Always use boiled or chlorinated water (17, 21). 
Treatment: The treatment of this infection varies with 
case and place of infection. Many drugs may be used. The 
following tables list these drugs, their characteristics 
and uses. ·,,, 
Drugs which are Used to Treat Amebiasis 
Case 
Asymptomatic 
Drug of Choice 
Diiodohydroxyquin 
65 mg tid x 20 days 
OR 
Diloxanide Furoate 
500 mg tid x 10 days 
Alternative 
Metronidazole 
75 mg tid x 
10 days 
Mild infection Paromycin 25 mgfkg Metronidazole 
in 3 doses for 10 days 
+ Diiodohydroxyquin 





Hepatic Abscesses Metronidazole 
750 mg tid x 10 days 
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Instructions for the Pharmacists (18, 19, 20) 
1. Most of the drug interactions, side effects, and adverse 
reactions of these medications should be known. 
2. Store these medications in a place protected from light. 
3. Tell the patient about any change in urine color, such 
as caused by Flagyl and chloroquine. 
4. Be familiar with the proper dose and the toxic dose and 
how to treat toxicity. 
5. Remember all of these notes: 
a. Flagyl, as well as other drugs, is contraindicated 
in pregnancy. 
b. Flagyl and chloroquine change urine color. 
c. Paromycin.interacts or interferes with absorption--
the malabsorption syndrome. 
d. Diiodohydroxyquin interferes with blood tests. 
e. Emetine may cause hypotension and cardiac arrythmias. 
It should be monitored in a hospital (ECG). 
f. Avoid emetine during pregnancy. 
g. Use emetine with caution in elderly. 
h. Emetine is contraindicated in cardiac problems, or 
renal problems. 
i. Diiodohydroxyquin is contraindicated with an impaired 
kidney or liver. 
j. Corticosteroids therapy should be avoided if the 
patient has amebiasis because corticosteroids may 
enhance the severity of the disease. 
k. Chloroquine phosphate should also be avoided during 
pregnancy, hepatic disease, or in the case of 
alcoholism. 
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Instructions for the Patient (10, 19, 20) 
A. Be sure that you do not double the dose or take·another 
drug which may interact with your medication. 
B. Tell your Doctor about any symptoms that you feel from 
your medication. 
C. After you complete the course of the treatment return 
to the hospital for a follow up examination. 
D. It is recommended that if you have an infection, go 
with your entire family to be investigated. 
E. Do not take cortisone or an antiinflammatory drug as 
you may aggravate your problem. 
F. Remember that the cleaner your are the safer will be 
from infection recurring. 
Chapter 3 
TRACHOMA 
Trachoma is a major problem in Saudi Arabia and other 
Middle East countries. It is a chronic disease caused by 
Chlamidia trachomatis, and is considered the leading cause 
of blindness in the world. It is an infectious disease, 
highly contagious, which infects the membrane lining of the 
eyelids, covering the front of the eye. The early or 
initial symptoms o.f this disease include redness in one or 
both eyes. The eye becomes swollen and the patient may 
feel a foreign body under the eyelids. Additionally, the 
patient is sensitive to light (photophobia) (22). 
The incidence of this disease is high among children 
of 8 to 10 years. The.disease may progress to a conjuncti-
val scar and this may shrink causing the eyelid to turn 
inward so that it blinks constantly. It also may lead to 
corneal ulceration which can cause blindness (23). Acute 
inflammation, combined with upper respiratory infections 
such as sinusitis and otitis, is common. The chronic 
infection may produce kerato conjunctivitis which, involving 
the cornea, turns to scar formation and reduces capacity 
for sight (24, 25). 
The causative agent is a Chlamydia, an obligate intra-
cellular parasite. It has some characteristics of both 
virus and bacteria. It is similar to a virus in its 
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intracellular nature but differs by having DNA and RNA. It 
is similar to bacteria but lacks the mechanisms to produce 
energy and therefore, depends on the host cells. It can 
survive in the host cells and multiply by binary fission. 
These Chlamydia are incapable of synthesizing ATP and the 
host cells supply them with it. The genus is Chlamydia, 
but this is further categorized as Chlamydia trachomatis, 
Chlamydia psittaci. The chlamydia trachomatis is involved 
in trachoma and other diseases such as bilateral interstitial 
pneumonia, nongonococcal urethritis, salpingitis, cervi-
citis, and conjunctivitis (22). 
It occurs worldwide, but is endemic in the Middle East. 
The high prevalence is due to first, the poor hygiene of 
the society; second, the crowded living conditions; third, 
the dusty windy weather also helps to increase the preva-
lence (22, 23, 24). The reservoir and the source of this 
infection is children under age 10, and usually under age 
five (23). The methods of transmission are numerous, but 
the most important factors are: 
1. close contact eye to eye 
2. birth canal infection, especially in the newborn 
3. flies may carry Chlamydia from the discharge of 
an infected eye. 
4. certain articles which come in contact with an 
infected person. 
Trachoma is considered the disease of the family, 
especially in a crowded family with many children. Reinfection 
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is common especially in children in an area where trachoma 
is endemic (23). The infection is characterized by intra-
familial transmission in Saudi Arabia (28). The infection 
may be latent. The infection does not express itself until 
a period of time when a person visits an endemic area, and 
anyone who has not had childhood trachoma may develop acute 
trachoma later. 
The diagnosis is based on: 
1. eye exam 
2. looking under the microscope for cytoplasmic 
inclusion bodies 
3. Chlamydia isolation 
4. human serology (complement fixation) (22) 
To prevent the infection on the individual person 
level, there are some guides to follows: 
1. apply ointment (antibiotic) on each eye of newborn 
baby. 
2. exclude the infected child from school. 
3. improve the standard of cleanliness to avoid 
infection. 
4. do not use the articles whic~ belong to others 
who are infected. 
5. use your own personal towels or articles which 
belong to you. 
6. do not have contact with an infected patient. 
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There are several methods to control this infection on 
the societal level. 
1. the most important factor is the education of the 
people to improve their personal hygiene. 
2. educate the people to use individual towels, and 
toilet articles, and do not use other people's 
articles. 
3. control flies by screening the doors and windows, 
and using suitable chemical sprays. 
4. remove the garbage and eliminate the flies' 
breeding place. 
5. begin investigation and screening of all preschool 
children, and treat the infected child. 
Treatment: Tetracycline orally is the drug of choice 
for treatment of Chlamydia infection. It is bacteriostatic 
which inhibits the protein synthesis of Chlamydia. There 
are three types of tetracycline: short acting, intermediate, 
and long acting. They are available in different dosage 
forms: capsules, tablets, injections, and also ointment 
1% - 3% as tetracycline hydrochloride. The usual dose is 
typically: 1% - 3% ointment, tablets of 250 mg or 500 mg 
three times daily for an adult (26). 
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Instructions to the Pharmacist 
1. Tetracycline will interfere with bone growth. Avoid 
dispensing tetracycline to pregnant women or young 
children. 
2. Tetracycline is used with caution especially in renal 
failure patient. 
3. Avoid dispensing Tetracycline to children up to 12 
years of age because it will cause permanent discolora-
tion of child's teeth. 
4. It should not be given with any hepatotoxic agents. 
5. Tetracycline may cause a deficiency in folate and 
cause anemia. 
6. Protect tetracycline from light to avoid photodegrada-
tion. 
7. Remove any tetracycline with darkening or change in color 
from your counter. 
8. Tetracycline loses potency of approximately 10% when it 
is stored at 370 for 2 months. 
9. Be sure you give the patient the adequate dose and be 
sure that he is not taking cortisone or antacids with 
it. 
10. Tetracycline has· many side' effects, including 
Gastrointestinal disturbance, vitamin deficiency, in-
crease incidence of infection by Giardiasis, teeth 
discoloration (in children) photosensitivity, and in-
creased fat in the liver. (29). 
11. Erythromycin can be used as alternative to tetracycline. 
68 
Instruction for Patient 
1 .. You should not take tetracycline with milk or butter-
milk because these contain magnesium and calcium which 
decreases absorption of the tetracycline. 
2. Be sure you do not take tetracycline with alcohol be-
cause alcohol increase the metabolism of tetracycline. 
3. Be sure do not mix tetracycline with antacid because 
this will decrease the absorption of tetracycline. 
4. Do not take tetracycline especially if you are preg-
nant or nursing a child. 
5. Avoid the sunlight especially for a long time because 
of photosensitivty. 
6. Report any side effects or adverse reactions to your 
physician or pharmacist. 
Chapter 4 
SEXUALLY TRANSMITTED DISEASES 
There are many sexually transmitted diseases. The 
route of transmission is the same but the causative agents 
are different. The most common sexually transmitted diseases 
are described, and emphasized will be gonorrhea, being the 
most common in Saudi Arabia. The incidence of these 
diseases is different from one disease to another. The 
most common diseases shown in the following pages are 
adapted from American Pharmacy, Vol. NS20, No. 8, August 
1980, page 35. 
The first disease is gonorrhea; the symptoms of 
gonorrhea are different for the male than for the female. 
In women it is usually asumptomatic; but if there are symp-
toms they are usually characterized by vaginal discharge 
and cystitis. In the male symptoms are dysuria, urethral 
discharge, and pain during urination (30). 
The diagnosis of gonorrhea depends on the microscopic 
examination and culture of the microorganism. The treatment 
of gonorrhea is by antibiotics such as Penicillin G, 4.8 
million units by intramuscular injection in two different 
sites. Probenecid is used orally to enhance or increase 
the peak serum of penicillin. The alternative is tetra-
cycline--0.5 gm orally, four times daily, for 5 to 10 days. 
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Gonorrhea is an infectious disease caused by Neisseria 
gonorrhoeae. Neisseria gonorrhoeae is gram negative diplo-
cocci bacteria. The host of this gram negative bacteria 
is the human. It causes a frequent purulent urethritis in 
men and purulent vaginitis in women, purulent conjunctivitis 
in the newborn child, and gonococcal proctitis in both women 
and men. Also Niesseria Gonorrhaeae causes salpingitis 
(pelvic inflammation in women) and also purulent arthritis 
(31). If the infection is not treated it may cause septi-
cemia with pustulor skin lesions, fever, and chronic prosta-
titis, especially if it disseminates (32). 
The symptoms of Gonorrhea in men are purulent urethral 
discharge, dysuria, frequent urination, and it may be 
asymptomatic. This asymptomatic infection is the frequent 
source of infection and it works as a carrier. The symptoms 
of gonorrhea in women are dysuria, frequent urination, an 
increase in vaginal discharge, abnormal menstrual bleeding, 
anorectal discomfort, cystitis, and also may be asymptomatic. 
The occurrence of purulent urethral discharge for four 
to ten days after sexual contact is sufficient evidence to 
make presumptive diagnosis. In women this is very difficult 
because the asymptomatic is most common. 
Diagnosis Gonorrhea in women depends on: 
1. A smear looking for intracellular gram negative 
bacteria diplococci. 
2. Thayer-Montin Media, culture the exudate in enriched 
chocolate agar with some antibiotics such as vancomycin, 
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nystatin to eliminate the growth of other bacteria or fungi. 
The specimen should be taken from the endocervical of the 
woman. 
3. Coagulatination test. 
4. Serological test especially the tests which dis-
tinguish syphilis from gonorrhea. 
Transmission of the Microorganism--
The major route of transmission is by sexual contact 
of an infectious person. There is a myth that gonorrhea or 
other sexually transmitted diseases are transmitted by 
articles or by the hands (33). The second route of trans-
mission is the infected birth canal. The newborn can be 
infected especially in the eyes. This may result in 
gonococcal ophthalmia neonatorum especially if the 1% 
silver ni~rate drops or antibiotic eye ointments are not 
administered (34). 
How to Prevent the Infection 
1. Use a condom during sexual contact. 
2. Urination immediately following intercourse may be 
helpful, especially in men. 
3. Washing the genitalia with water and soap. 
4. Use antibiotics cream or foam for prophylaxis. 
5. Some have recommended Penicillin G in a dose of one 
million units immediately before and after. 
6. To prevent the gonococcal ophthalmia neonatorium, apply 
to the eyes of newborn 1% silver nitrate solution or 
an antibiotic ointment. 
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The second disease is syphilis (31), of which there 
are two types: primary syphilis and secondary syphilis. 
The primary syphilis is characterized by a painless chancre. 
Secondary syphilis is characterized by cutaneous and mucous 
membrane lesion, alopecia, and generalized lymphoadenopathy. 
The diagnosis of syphilis is derived by a VDRL (Venereal 
Disease Research Laboratory) test or RPR (Rabid Plasma 
Reagin) or by use of an electron microscope. The treatment 
of syphilis is by benzathine penicillin G--2.4 million units 
IM, or procaine penicillin G--4.8 million units (600,000 
units IM daily for 8 days). 
The third disease is nongonococcal urethritis (NGU). 
It is characterized by urethral discharge, purulent or mucoid. 
The diagnosis depends on the clinical picture of the symp-
toms. It also depends on the microscope and culture to 
distinguish NGU from the Neisseria gonorrhoeae. The usual 
treatment is tetracycline, 0.5 gm four times daily for 
21 days. 
The fourth disease is trichomoniasis, a protozoan 
infection (T. vaginalis). It is characterized by erythema 
and edema of the external genitalia, a greenish-gray vaginal 
discharge, or it may be asymptomatic. The diagnosis depends 
on the micDoscopical examination of the discharge and the 
treatment is Flagyl, 2 gm orally, or 250 mg three times 
daily for seven days. 
The fifth disease is virus-caused genital herpes. This 
infection is characterized by vesicular lesions in the 
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vulva, vagina, and the cervix in the women, or lesions 
in penis prepuse and scrotum in men. The diagnosis is made 
by microscopical examination to eliminate other diseases. 
There is no specific treatment. 
The sixth disease is vulvovaginal candidiasis--a mycotic 
infection. It is a common infectious disease of the vulva. 
It is characterized by erythematous and edematous vaginal 
discharge which is characterized by a white, thick color. 
The diagnosis depends on the culture or by the microscopical 
examination. The treatment is nystatin vaginal supposi-
to~ies inserted twice daily for 14 days. 
The seventh disease is Corynbacterium Vaginale Vagi-
nitis. This disease is characterized by gray white discharge 
and vulvular irritation. The diagnosis depends on the 
clinical picture of the symptoms and also the microscopical 
examination. The treatment is by ampicillin--500 mg every 
six hours for 10 days." 
Anther problem is pediculosis pubis, known as "Crabs," 
which is characterized by erythematous, itching papules. 
Nits, larvae or adult lice stick to the hair around the 
pubic area or hair around the anus. The diagnosis depends 
on clinical observation of lice. The treatment is usually 
1% gama benzene hexachloride lotion or 25% benzyl benzoate 
lotion combined with antibiotics to prevent secondary 
infection. 
The next disease is Scabies. This infection is char-
acterized by the red papule which containes the mite. The 
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scratching may produce excoriation. This is most common on 
fingers, wrists, elbows, ankles, and waist. It is charac~ 
terized by night-time itching. The treatment is as for 
pediculosis. 
Genital Warts is a disease characterized by pinkish 
papillary growth which occurs around the vulva introitus. 
The diagnosis depends on the clinical appearance and his-
tological observation. The treatment is podophyllin; 10-25% 
in tincture of benzoin, applied weekly. 
Chancroid is a tender ulcer (soft chancre). The base 
of this ulcer is covered by yellow or gray necrotic exudate. 
The diagnosis depends on the clinical appearance and on the 
test which distinguishes the Chancroid from syphilis. The 
treatment is by sulfisoxazole--1 gm orally four times. 
Lymphogranuloma venereum, is characterized by painless 
vesicles or superficial nonindurated ulcers on the genitalia. 
This is diagnosea by the clinical picture or by the comple-
ment fixation test. The treatment is by tetracycline--500 mg 
orally four times a day for 2 to 3 weeks. 
The disease granuloma inguinale is detected by sub-
cutaneous nodules which erode through the skin producing 
clean granulomatous beefy red lesions. The diagnosis depends 
on the clinical picture. The treatment is tetracycline 
0.2 gm four times a day for 3 weeks. 
Hepatitis Type B is an insidious onset infection char-
acterized by abdominal discomfort, anorexia, nausea, vomiting. 
If this disease progresses it may lead to jaundice. 
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Instructions to the Pharmacist 
1. First of all, do not prescribe any medication to any 
person who thinks they may have a sexually transmitted 
disease unless he has first seen a doctor. 
2. Learn the current treatment schedule for uncomplicated 
gonorrhea. 
3. Tetracycline should be avoided in pregnant women. 
4. Remember there may be drug interactions with tetra-
cycline, such as with antacids or milk products. 
5. Probenicid is used with penicillin to increase the peak 
serum level of penicillin. 
6. Probenicid may cause nausea, vomiting, precipitate uric 
acid stone and primary gouty arthritis. 
Instructions for the Patient 
l. If you have the symptoms of gonorrhea do not hesitate 
to visit the doctor as soon as possible. 
2. The treatment is usually penicillin. If you are sensi-
tive to penicillin tell your doctor. 
3. Avoid contact with your partner(s). 
4. Personal cleanliness is important. 
5. Avoid the causes which lead to reinfection. 
6. If you have gout tell your doctor because he may 
prescribe probenicid. 
7. Pregnant women should avoid tetracycline. 
8. Follow the treatment accurately (30, 32). 
Chapter 5 
PEPTIC ULCER 
Peptic ulcer is a term used to represent the ulcerative 
disorder of the upper gastrointestinal tract. Peptic ulcer 
includes three different types of ulcers, gastric ulcer, 
duodenum ulcer, and Zollinger-Ellison syndrome (35). Each 
of these three ulcers varies in incidence and specific char-
acter (37). 
The incidence of peptic ulcer in the male is higher 
than in the female because of the hormonal protection in the 
female. The duodenal ulcer is more common than the gastric 
ulcer, and more common in younger people between 25-50 years; 
in contrast, gastric ulcer is more common in older people. 
The differences between gastric and duodenal ulcer are in 
areas of location, severity, and cause (36). First, the 
location of the duodenal ulcer is in the first segment of 
duodenum but the gastric ulcer is found on the wall of 
the stomach, making treatment more difficult. Secondly, 
the duodenal ulcer is a benign ulcer, while the gastric ulcer 
may be malignant. Finally, the amount of hydrochloric acid 
secretion differs from the gastric ulcer to the duodenal 
ulcer. The acid secretion associated with a duodenal ulcer 
is more than the normal which would exist with no ulcer; and 
in the gastric ulcer, the secretion is normal or may be 
lower than normal. 
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There are several causes of the duodenal ulcer. These 
causes may be endogenous or exogenous. The endogenous 
causes are increasing vagus nerves stimulation, increasing 
gastric and secretion or gastric acid overproduction, increas-
ing vulnerability of mucosa, gastric mucosal atrophy and 
the inflammation of gastroduodenum mucosa (gastritis) (37). 
The exogenous causes which may lead to ulceration are 
stress (which includes emotional stress, stress due to opera-
tions), burns, or a type of stress prone personality known 
as Type A personality. Genetic factors may have an influ-
ence such as blood group 0. Also, drugs which may induce 
ulcers are most common, and numerous. Some of the more 
important drugs are aspirin, phenylbutazone, indomethacin, 
reserpine, alcohol, caffeine, cigarettes, potassium chloride 
tablets, and corticosteroids. Reserpine and caffeine 
increase acid secretion; and alcohol causes gastritis as 
well as local irritation (37). 
The symptoms of peptic ulcer (duodenal ulcer) are epi-
gastric pain, characterized by "heart burn,'' an increased 
sensation of hunger, and fullness in the right middle 
epigastrium especially about 90 minutes after eating. This 
pain is relieved by food or by using an antacid or even 
vomiting. Also, there are symptoms of the gastrointestinal 
tract which include nausea, vomiting, indigestion, consti-
pation, and the vomit may contain blood (coffee ground 
vomiting( (35, 37). 
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There are several complications associated with peptic 
ulcer. 
A. A chronic loss of blood causing anemia, i.e., 
hypochromic microcytic anemia. 
B. The ulcer may penetrate the stomach wall and include 
other organs such as the pancreas. 
C. Perforation may occur in which the ulcer eats the 
gastric or duodenum wall due to erosions to the pentionium 
cavity. Food which is contaminated enters the cavity caus-
ing peritonitis and septicemia. Besides these, there may 
be pyleoric obstruction with continuous vomiting. 
The diagnosis of peptic ulcer is usually made with the 
first signs and symptoms. The pain which is relieved by 
food or antacid is evidence or at least a suggestion of 
duodenal ulcer. Also, there are several x-ray examinations. 
The barium examinations of the upper gastrointestinal tract, 
endoscopy, intragastric photography, or the multiple purpose 
endoscope (36) are used to diagnose this condition. 
The treatment of peptic ulcer is basically life-long. 
The goal of treatment is to prevent the recurrence of the 
ulcer and to heal the present ulcer, by decreasing gastric 
acidity and to relieve pain and stress. 
First of all, diet is very important. The diet must 
be nutritious with a restricted intake of gastric irritants; 
such as alcohol) coffee, tea, chilies, peppers, or other 
hot foods. It is recommended to take frequent small meals. 
Using milk to neutralize the acid has some advantage, but 
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there are disadvantages. Milk has poor neutralizing power, 
and is also rich in lipids which may increase chances of 
heart diseases. Also, milk protein increases acid secre-
tion and has a high amount of calcium which influences the 
heart function. 
The second step is the use of antacids. Antacids 
neutralize acid, but have no healing function or cure. 
Antacid drugs are selected based upon the neutralization 
capacity and sodium content. The best antacid is an antacid 
which has high neutralizing power, and an absence of acid 
rebound, with no constipation or diarrhea as adverse reac-
tions, or side effects. Also, a good antacid has no influ-
ence on the electrolyte balance. 
There are several antacid preparations and some of 
these are: sodium bicarbonate preparations, which are 
potent and short term, rapidly acting, but may cause 
systemic alkalosis if a more than 200 m Eq NaHC03 Sodium 
Bicarbonate to a patient under the age of 60 years old, or 
if given by 100 m Eq to a patient above 60 years old. The 
second preparation which frequently described is aluminum 
hydroxide, and it causes constipation. It may be pre-
scribed alone or with magnesium hydroxide to neutralize 
the acid and the side effects of aluminum hydroxide. The 
third preparation is magnesium hydroxide and it is poorly 
absorbed by the intestine and may cause osmotic diarrhea. 
It is used usually in combination with aluminum hydroxide. 
The fourth preparation contains calcium carbonate, and 
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prolonged use may cause adverse reactions such as producing 
calculi, acid rebound and hypercalcemia. Anticholinergic 
drugs such as atropine and probanthine but they are not 
,recommended. This group is not recommended because the 
amount of drug to neutralize or to inhibit the vagus is 
close to the toxic dose. The side effects of these medica-
tions are dry mouth, blurred vision, confusion, and may 
cause tacchycardia (37, 38, 40, 41). 
The next group is H2 antagonists, or histamine antago-
nists. Emetidine (tagamet) is an example of this group and 
the usual dose of cemitidine (tagamet) is 300 mg four times 
daily. It is used as a prophylactic as well. The side 
effects may induce mastitis, and maybe mental confusion, 
especially in old people. The last solution or treatment 
is surgery. Surgery is not done except if there is a high 
recurrence rate or frequent complications such as penetra-
tion, perforation, or obstruction. Surgery is also done 
when there is a malignancy (40). 
In conclusion, the selection of antacids dep~nds on the 
situation of the patient and the diagnosis. The patient may 
have heart failure and need restricted sodium intake. He 
must be treated by low sodium antacids. Also the treatment 
complication which is associated with peptic ulcer is very 
important. It is very difficult to manage a patient with 
peptic ulcer who also has rheumatoid arthritis or gout. Remem-
ber that you should not prescribe any medication without having 
proper information and background on the patient. 
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Instructions for the Pharmacist 
1. Remeber that all of the drugs which are used to neu-
tralize acids may have interactions with other drugs. 
a) Tetracycline should not be administered with an 
antacid. 
b) With digitalis it is very important to monitor the 
dose. Antacid impairs the absorption. 
c) Naproxen absorption is delayed by an antacid. 
d) An antanid increases the levodopa absorption. 
e) An antacid decreases iron absorption, especially 
magnesium trisilicate. 
f) Indomethacin is inhibited by an antacid due to 
decreased absorption. 
g) An antacid reduces the rate of librium absorption. 
h) Oral anticoagulents should not be used with an 
antacid. If the patient needs to use ah anti-
coagulant, he should use only warfarin. 
2. Remember the list of ulcerogenic drugs such as aspirin, 
indomethacin, phenylbutazone, cortisone, reserpine, and 
potassium chloride tablets. 
3. Remember that the patient who has a peptic ulcer may 
develop hypochromic microcytic anemia (iron deficiency 
anemia). 
4. Remember that these drugs should be taken 1 hour after 
a meal except if the physician orders otherwise. 
5. Remember the dose must be reduced if the patient has 
renal insufficiency. 
6. Selection of the antacid is based upon the neutralizing 
capacity and also upon the sodium content, especially 
with a patient who has a peptic ulcer and other dis-
orders, such as hypertension and congestive heart 
failure. 
7. There are many products. The most common are listed 
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(Adapted from the Handbook of Clinical Drug Data, p. 377). 
8. You may find other preparations which are used to 
treat Peptic Ulcer especially from Europe, such as 
licorice derivatives, or antipepsins, or antigastrics. 
9. Some use hormones such as estrogen (36). 
~ 
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Instructions for the Patient 
1. Avoid gastric irritant foods such as chilies, alcohol, 
tea, green chilies, hot peppers, smoking, cola, coffee, 
or any type of food or activity you feel is a gastric 
irritant. 
2. Avoid the ulcerogenic drugs such as asp1r1n, indometha-
cin, phenylbutazone, reserpine, potassium chloride 
tablets, and cortisone. 
3. Take rich nutritional food in small meals many times 
a day. 
4. Use the antacid which your physician prescribed for you 
and report anything about the drug to your physician. 
5. Rep0rt any side effects of tagamet to your physician. 
6. Avoid situations which lead to stress, accept the 
disease and therapy and learn how to manage it. 
7. Remember that ulcers are never completely healed and 
may recur. You must use the antacid as long as you live. 
8. Visit your physician regularly (37, 41). 
Chapter 6 
IRON DEFICIENCY ANEMIA 
Iron deficiency anemia is the most common anemia in 
Saudi Arabia, as it is world wide. It occurs especially in 
pregnant women and in preschool children, although found 
in all ages. Iron deficiency anemia is microcytic hypo-
chromic anemia, meaning the red blood cells are small and 
pale. The hemoglobin is very important for the transpor-
tation of oxygen and carbon monoxide from tissue to the 
lungs. When iron deficiency occurs, the production of the 
blood cells is less effective and the formation of the 
hemoglobin content is affected. The red blood cells, being 
small. and pale, reduce the capacity of the blood to maintain 
normal oxygen transportation (43). 
The symptoms of iron deficiency anemia are numerous 
and depend on the degree of the severity of 'the deficiency. 
Most cases are asymptomatic, but if a case is symptomatic, 
it will be manifested by these symptoms: fatigability, 
faintness, palpitations, shortness of breath, headache and 
pallor. Pregnant women as well as children may feel a 
strange appetite which is called pica; there is often an 
abnormal appetite for clay, ice and other things that are 
not fit for food. 
There are several causes of anemia due to iron defi-
ciency (44). The first cause is an imbalance in diet. Iron 
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is naturally absorbed and the excess is deposited in storage, 
as the body's reserve, in the hepatic epithelium. The 
daily iron requirement differs from one individual to 
another. For example, the normal man and non-menstruating 
woman need 5-10 mg daily. The menstruating woman needs 
7-20 mg daily. The pregnant woman needs 20-40 mg daily. 
Iron is found in the following kinds of foods: liver, meat, 
whole grains, potatoes, egg yolks, green vegetables, and 
fruits (43). It is very important that there be an adequate 
diet with a good selection of the above for children, 
especially preschool children. The infant after six months 
of age will deplete all of the iron storage which he had from 
his mother. Now he needs iron from external sources. Chil-
dren often develop milk anemia due to lack of iron in their 
Xood. The second cause is the failure to absorb the iron 
from the food which is ingested. This cause may be secondary 
to gastrointestinal diseases or malabsorption (45). The 
third cause is loss of blood. This is the most common 
cause of iron deficiency anemia. The chronic loss of blood 
causes the iron deficiency and develops the anemia. This 
cause can be resultant from several factors. 
a. Ulceration in the gastrointestinal tract~ such as 
peptic ulcer of duodenal ulcer, leading to iron 
deficiency. 
b. Hookworm infection which will consume the food and 
also cause internal bleeding. The hookworm produces 
~--
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chronic bleeding and the iron escapes with the 
b1ood. 
c. Drugs, such as aspirin and phenylbutazone, may 
also induce irritation and bleeding in the gastro-
intestinal tract. 
The fourth case is frequent pregnancy. Pregnancy 
increases the demand for as well as the loss of iron because 
of the large amount of blood lost during labor. Infections 
such as tuberculosis or autoimmune diseases such as rheuma-
toid arthritis will prevent iron utilization and cause iron 
deficiency .anemia. Finally, lack of hydrochloric acid, or 
lack of Vitamin B6 may cause anemia (44). 
The diagnosis of iron deficiency anemia depends on the 
severity of this deficiency. When iron storage has been 
depleted, plasma iron falls and erythropoesis is curtailed. 
Red blood cells may be morphologically normal (normocytic). 
The results of iron deficiency may be one or more of 
these: 
a) Plasma iron level is decreased. 
b) Iron binding capacity is increased. 
c) Transferrin saturation is about 5-15% and the 
normal is usually 10-20%. 
d) Sideroblasts are decreased. 
e) The morphologic shape is normocytic or microcytic 
hypochromic. 
There are some laboratory tests such as a) microscopical 
examination of smear of marrow aspirate for hemoiderin 
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granules, b) the plasma levels iron values decreased, and 
c) if the level is less than 50 mgjlOOml then the patient 
is considered anemic. 
How to Prevent Iron Deficiency Anemia 
A) A good diet containing meat, liver, eggs, and green 
vegetables is very important to maintain adequate iron 
level. 
B) Do not depend on one kind of diet such as rice, and do 
not eat at irregular intervals, or miss breakfast. 
C) Pay attention to the children and their diet. Give 
them foods containing iron. 
D) Pay attention to a child, to see if he has pica, and 
the pregnant woman should pay attention to her own 
appetite. 
E) Correct the causes of the iron deficiency before you 
treat anemia. 
F) Vigorous exercise should be avoided if you have anemia. 
G) Pregnant women should visit the physician regularly 
during pregnancy (43)~ 
.The treatment of iron deficiency anemia is simple. Just 
treat the cause by giving iron supplement (47). There are 
oral preparations which are ferrous salts such as sulfate, 
gluconate, and fumarate. The usual oral dose is 200 mg 
daily. The oral iron supplement is preferable to the 
parenterally supplement. 
The parenteral supplement is iron dextran. This injec-
tion is not recommended except when there are some factors 
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which force you to use it. These factors are: oral malab-
sorption, serious gastrointestinal disturbance, ulceration 
in the stomach or in any part of the gastrointestinal tract, 
and gastrointestinal infection. 
The iron supplement which is given orally is transported 
across the intestinal mucosa and it is carried by transferrin 
to the erythroid marrow. The parenteral iron dextran is 
metabolized by the liver parenchyma and reticuloendothelial 
cells. Then the iron containing carbohydrates split, and 
the free iron is carried by transferrin to the bone marrow. 
The dose of ferrous sulfate is 200 mg twice daily for 
at least three months (44). The side effects of iron prepa~ 
rations may be gastrointestinal irritation, constipation, 
diarrhea, stained teeth, and sometimes acute poisoning, 
especially in children (49). 
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Instructions for the Pharmacist 
A. All iron preparations should be labeled "Caution! Keep 
out of reach of children." Acute poisoning is very com-
mon among children. A dose of 1 gm can cause acute 
poisoning. · 
. The symptoms of poisoning: 
Gastric irritation, necrosis, nausea, vomiting, 
shock, pallor, cyanosis, drowsiness, and the 
stool color is green. 
Treatment: 
1. Induction of vomiting 
2. Administration of eggs and milk 
3. Gastric lavage 
4. 1% sodium bicarbonate to-convert iron to a 
less soluble compound. 
5 .. Chelating agent may be used such as deferoxamine. 
B. You will see more than 40 or more oral preparations of 
iron. Some have intrinsic factors, and some vitamins 
such as folic acid. There is no advantage to these 
additions. The simplest and bestipreparation is ferrous 
sulfate. 
C. Iron preparations affect a blood test, especially 
billirubin. Iron dextran gives falsely positive 
results. 
D. Iron darkens the urine, due to the sulfide. 
E. Iron dextran is given intravenously. This route is 
safer than intramuscular. It is given in a dose of 
500 mg, by slow administration. 
F. Some drugs inhibit absorption of iron from the gastro-
intestinal tract. There antacids, tetracycline, 
vitamin E, pancreatic extract and penicillimine. 
G. Coated tablets decrease the absorption of iron because 
the best site for absorption of iron is the upper 
gastrointestinal tract (43, 45, 47, 48). 
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Instructions for the Patient 
A. The oral iron pr~paration should be taken with a full 
glass of water 1 hour before meals or two hours after 
meals. 
B. If there is nausea or vomiting, take the oral prep-
aration during the meal. 
C. If you use an antacid, be sure that you do not take it 
with iron because antacids decrease absorption. · 
D. Keep out of the reach of children. As acute poisoning 
is very common. One dose of the medication may be toxic 
to your child. 
E. Tetracycline will decrease absorption of iron.· 
F. Do not miss any dose as it will contribute to the failure 
of the treatment (48, 49). 
Chapter 7 
RHEUMATOID ARTHRITIS 
There are several rheumatic diseases. These are rheu-
matoid arthritis, osteoarthritis, gout, ankylosing spondy-
litis, palymyalgia, vasculitis, rheumatic fever, juvenile 
chronic polyarthritis, and others (51). In the following 
pages rheumatic arthritis will be discussed as an example 
of rheumatic disease. 
Rheumatic arthritis is considered a chronic disease 
of unknown causes (52). This disease is evidenced by inflam-
mation of one or more of the joints. It usually begins with 
simple inflammation, becoming warm and swollen. If the 
disease progresses it can cause development of granulation 
tissues, called pannus formation. This granulation begins 
to destroy the articular ~artilage catising pain and erosion 
of the cartilage. The surface of the cartilage is converted 
from a smooth surface to a rough one, leading to subluxation 
or dislocation of the joint. The late stage is charac-
terized by ankylosis (rigidity of the joint),:~Which leads 
to deformities (52). 
Some of the signs and symptoms of rheumatoid arthritis 
are fatigue and muscle weakness, swollen joints which may 
be symmetrical, limitation of joint movement or motion, 
prolonged morning stiffness, and difficulty in walking. 
Also an increased incidence of colds with low grade fever. 
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Rheumatoid arthritis is classified into three cate-
gories, dependent on diagnostic criteria. Classical rheuma-
toid arthritis, definite rheumatoid arthritis, and probable 
rheumatoid arthritis. Those diagnostic criteria include: 
a) the patient may have morning stiffness. 
b) the patient feels pain and he finds that motion 
is very difficult. 
c) the patient notices swelling in at least one joint. 
d) x-ray findings are positive. 
e) rheumatoid factors are positive. 
f) histological change in nodules or in the synovial 
fluid. 
g) subcutaneous nodules are present. 
It is considered as clinical if most of these symptoms are 
found in one patient (51, 52). Rheumatoid arthritis is 
limited to the joints, and is more common in women than in 
IIJ.en. 
The blood analysis of rheumatic patients is charac-
terized by these findings: 
a) the red blood cells are normocytic hypochromic. 
b) the serum of the patient will show a deficiency in 
iron concentration. 
c) the white blood cell count will be elevated. 
d)~.the erythrocyte sedimentation rate is elevated. 
e) the blood protein, especially globulin, is elevated 
due to increasing synthesis of antibodies IgG, 
IgM, and IgA. 
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The diagnosis of the disorder partly depends on the 
results of laboratory tests such as: 
a) those which measure the erythrocyte sedimentation 
Tate. 
b) serological test, looking for rheumatic factors 
or antinuclear antibodies. 
c) X-ray findings. 
d) analysis of the synovial fluid. 
Rheumatoid arthritis is a very dangerous disorder especially 
if it progresses. There are some extra articular manifes-
tations of this disease. Those manifestations are: 
a) anemia (normocytic hypochromic anemia). It is 
considered the most active manifestation of rheuma-
toid arthritis. 
b) rheumatoid nodules--They are located on the surface 
of elbows or the external surface of the fingers. 
These nodules may breakdown and cause the drainage 
of fluid and become the spot of infection. 
c) nail-fold-thrombi--This may lead to gangrene as 
well as ulceration. 
d) pulmonary fibrosis--This is characterized by inter-
stitial fibrosis! and nodules in the parenchyma. 
e) pericarditis, splenomegaly, and lymphoadenopathy 
are involved in the late manifestation of rheuma-
toid arthritis. 
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What to do if you have Rheumatoid Arthritis 
1. The earlier you begin treatment, the more benefit 
you Will-'get from it. 
2. It is important to know a little bit about this disease 
to build a positive attitude regarding this disease. 
3. The physical therapy including training procedures and 
the use of heat can help to relieve pain. 
4. Be aware of possibility ofdeveJ:oping anemia. 
5. The treatments by medications are important, and rem-
ember those drugs, which are usually used. 
6. Maybe tha_doctor will prescribe to you corticosteroid 
or gold salts or penicillamine. 
7. Surgery may be done if needed. 
The treatment of rheumatoid arthritis depends on the 
stage of the disease and the response to the medications. 
There are several lines which the physi(cian must follow. 
The fist line of treatment: 
Aspirin in large doses. 
Second line of treatment: 
A rapid-acting ilion-steroid anti-inflammatory such as 
Ibuprofen - (Mortin) 
Naproxen - (Naprosyn) 
Fenoprofen - (Nalfon) 
Tolmetin - (Tolectin) 
Sulindac - (Clinoril) 
Third line of treatment: 




Fourth line of treatment: 
1. Gold Salts 
2. Penicillamine 
3. Anti-Malaria drugs 





2. ACTH injection 
3. intra-articular injection (51) 
The first line of therapy is aspirin. It is the drug 
which the physician usually prescribes. The physician 
usually does not go to another drug until there is no response 
to the aspirin or side effects of the drug appear. Aspirin 
is acetylsalicylic acid. It is a weak organic acid. It 
has antipyretic analgesic and anti-inflammatory properties. 
The lower doses of aspirin do not produce anti-inflammatory 
action as do large ones. Aspirin is absorbed directly from 
the stomach and upper intestinal tracts, being distributed 
throughout the body. It will pass through the placenta (53). 
Aspirin also is found in the cerebral spinal fluid. It is 
bound to the blood protein especially albumin. Its excre-
tion in the urine is influenced especially by the pH level 
of the urine. The clearance of aspirin increasing if the 
urine is alkaline. 
The major side effects of aspirin are headache, dizzi-
ness, tinnitus, gastric irritation, gastrointestinal bleed-
ing, and ulceration, (especially peptic). The platelet 
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aggregation is decreased and may cause a bleeding disorder. 
There may be a hearing loss due to chronic use of aspirin (54). 
There are no differences or advantages to using one 
brand of aspirin over another or from using the buffered 
kind, if you take aspirin with large amounts of water or 
after eating meat. All of the brands contain aspirin and 
vary in their other additives. Bufferin contains 480 mg of 
aspirin with buffered aluminum glycinate and mg carbonate. 
Excedrin contains aspirin (280 mg) plus acetaminophen 
(250 mg), and caffeine (65 mg). APC is aspirin, phenacetin, 
and caffeine, and it is not recommended. 
The other medications are non-steroid anti-inflammatory 
such as phenylbutazone (Butazolidin) and oxyphenylbutazone 
(Tanderil). They are effective in reducing the synovitis 
of active rheumatoid disease. It hsould be used in short 
term therapy only because of side effects such as salt reten-
tion, peptic ulceration, rashes, and also hematologic abnor-
malities and disorders. Another drug is indomethacin (Indo-
cin). It has major side effects which are headache, confu-
sion, and peptic ulceration. If neither the aspirin nor the 
non-steroid anti-inflammatory (such as phenylbutazone or 
indomethacin) is effective fail, the gold salts may be 
used (55). 
The preparations of gold salts are: sold sodium thio-
sulfate, gold sodium thiomalate, gold thioglucose, and gold 
thioglyconate .. However, these can have side effects or 
cause adverse reactions, such as skin rash. Corticosteroids 
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may be used as systemic administration or topically, but 
they have contraindications and may cause adverse reactions 
such as depressed immune response (51). 
In Saudi Arabia, most medication can be obtained without 
~ ----
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a prescription except narcotics and tranquilizers. This 
causes a major'problem among the population. This problem 
may cause drug-drug interactions. 
for headache or arthritis is very common. The major drug 
interactions of aspirin and other drugs are: 
1. Alcohol causes gastrointestinal irritation. Aspirin 
with alcohol increases the risk of ulceration. 
2. Aminosalicylic acid potentiates aspirin and causes 
salicylism. 
3. Ammonium chloride increases the salicylate level 
due to the decreasing of the clearance. 
4. Ascorbic acid (Vitamin C) will increase the plasma 
level of aspirin. 
5. An anticoagulent such as Warfarin of which the 
major side effect is gastrointestinal bleeding and the use 
of aspirin will increase the risk of hemorrhage. 
6. Aspirin will increase the effect of oral antihyper-
glycemic agents and may cause hypoglycemia. 
7. Aspirin is to be avoided in the presence of gout 
because aspirin will increase the uric acid level (57). 
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Instructions to the Pharmacist 
1. Aspirin is hydrolized to acetic acid and salicylic 
acid when moist. Remove the product from your pharmacy 
if you notice an odor of acetic acid. 
2. Aspirin is not recommended for an infant under one year. 
3. Aspirin is used with caution in a patient with renal 
impairment. 
-------4-.-Be sure you unders-tana-tnedrug=Tnt-eract-ion oTa-spfr1n 
as there is a high chance o~ interactions. 
5. Aspirin interferes with the lab measurement of uric acid. 
6. Avoid dispensing phenylbutazone to a patient with 
congestive heart failure. 
7. A patient who is taking phenylbutazone should be warned 
to report any abdominal pain, fever, rashes, or swelling 
of the ankles. 
8. The treatment of the toxicity of phenylbutazone is by 
emptying the stomach and by giving sodium bicarbonate. 
9. All of these medications must be protected from light. 
10. There are now medications which are non-steroid anti-
inflammatories. They have less side effects, but they 
sho"uld not be used until there is aspirin failure. 
11. Be aware about the widespread availability of cortico-
steroids (53). 
99 
Instructions for the Patient 
1. Aspirin may cause peptic ulcer and gastrointest~nal 
bleeding. Take aspirin after meals and drink water 
with it. 
2. If you drink alcohol, do not take aspirin with it 




4. If you are a diabetic person and you are taking an 
oral hypoglycemic, do not take aspirin because aspirin 
may increase the hypoglycemic effect of these agents. 
5. Tell your doctor about any extra medications· you are 
using. 
6. Aspirin is contraindicated in pregnancy, gastric ulcer, 
or any bleeding of the gastrointestinal tract. 
7. Do not prescribe aspirin for yourself to treat arthri-
tis. You could, for example, have gout and aspirin 
would be contraindicated. 
8. Be aware if you take phenylbutazone. It must be used 
for a short period of time, and it should be taken 
after meals. 
9. Avoid indomethacin (Indocin) if you are taking an 
antipleptic drug. 
10. Avoid taking aspirin, indomethacin or phenylbutazone 
if you have a peptic ulcer, or bleeding. 
11. There are always new drugs, so be sure that you are 
informed about your medications and report any diffi-
culties to your doctor. 
12. Keep all medications out of the reach of children. 
13. Always report medications, symptoms and complications 
to your doctor. 
Chapter 8 
DIABETES MELLITUS IN ADULTS 
----
"" Diabetes mellitus is a chronic disease characterized 
by a disorder of the metabolism of carbohydrates, protein, 
and fat. Diabetes is associated with hyperglycemia due to 
the absolute absence of insulin or the reducflon-01-fhe-
effectiveness of insulin. These are two types of diabetes: 
the juvenile onset and adult onset diabetes (58). The normal 
metabolism of carbohydrates, fat, and protein, however, 
should be discussed bef6re the discussion of abnormal metab-
olism. After the normal person (non-diabetic) digests and 
absorbs sugar, the glucose goes into the circulation through 
the influence of the insulin which is secreted from the 
pancreas. It is utilized in different areas of the body 
excluding the brain, which utilizes glucose without the 
need for insulin. Insulin converts glucose to glycogen in 
the liver and the muscles; it increases glucose intake across 
muscle cells; it increases glucose utilization via the Krebs 
cycle in order to produce energy; it decreases the breakdown 
to the amino acids and the fatty acids to glucose; addi-
tionalLy, it increases the synthesis of fatty acids and 
triglycerides. Insulin increases glycogen synthesis and 




If the person does not eat, there is no exogenous sugar 
in the blood and the glycogen in the liver is converted to 
glucose. At the same time, the other mechanism, such as 
gluconeogenesis (synthesis of glucose from amino acids or 
another source rather than carbohydrates), has begun. Lack 
of glucose causes wasting the muscle, fat, and protein, and 
the body depends on its own storage of glycogen, protein, 
--------an-d-fat----to-pro-d u-c-e-glutm_s_e_;--an--<:rssen t-ial- s-ource -crf -ene-rgy-: -------- ----
In. the diabetic patient, there is glucose in the blood 
which cannot be utilized and the mechanisms upon which the 
fasting person depends to produce glucose are activated. 
Accumulation of blood-glucose (hyperglycemia) is responsible 
for many of the symptoms of diabetes (59). 
The major symptoms of diabetes are weakness, fatigue, 
weight loss, and polyuria, polydipsia, and polyhagia. Also, 
the diabetic may experience blurred vision, pain, muscle 
cramps, intensive itching, and slow wound healing. 
The following table is a comparison between the two 
types of diabetes mentioned earlier: juvenile onset and 
adult onset (60). 










Juvenile Onset Diabetes 
Rapid onset 
More severe 
Greater insulin deficiency 
Patient is thin 
Diet alone in inadequate 
No response to oral 
hypoglycemic agents 
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Adult Onset Diabetes 
Gradual onset 
Less severe 
Normal insulin, or higher 
than normal 
Obese patient 
____ Q!~~~_a_y_}:)_e_ ~d~gu~_!~ ________ _ 
Oral hypoglycemic agents 
are effective (59). 
The diagnosis of diabetes is based upon clinical tests. 
The diagnostic test is the oral glucose tolerance test. 
This test depends on determining the fasting blood sugar 
level two hours after administering 100 mg of glucose. If 
the person is non-diabetic, the blood sugar returns to a 
normal level within two hours after glucose loading. If 
the patient is diabetic he needs more time to return to 
normal. There are a number of other tests for screening 
and aids to diagnose, such as testing for glucose in the 
urine, or 2 hour postprandial blood sugar (58). 
If the person does not begin treatment for diabetes, 
there may be many complications associated with increasing 
blood sugar level. There are some complications which are 
acute, such as ketoacidosis and non-ketotic hyperosmolor 
coma. 
The later complications are increased tendency ror 
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myocardial infarction, congestive heart failure, tendency 
to myocardial rupture, and increase in the risk and severity 
of coronary artery diseases. Patients with diabetes are 
more liable to coronary disease than non-diabetics. Dia-
betics also may have decreased or lack of circulation in the 
extremities, particularly the feet, which may lead to gan-
grene. High blood sugar level increases the tendency to 
------
cerebral vascular accident and hemorrhage. A change in the 
metabolism of lipoprotein leads to the increase of the total 
lipid and cholesterol, and a decreaseof triglyceride clear-
ance, which lead to hypercholesterimia hyperlipidemia, a 
condition closely associated with atherosclerosis. 
Second, diabetes affects the retina in the eye, causing 
a chronic progressive disease which may lead to blindness. 
Diabetes is considered the most important systemic disease 
which causes blindness. 
Third, nephropathy is another dangerous complication 
which can lead to death due to kidney failure. In this case, 
there is glomerulosclerosis and a hyaline mass in the 
glomeruli. Also, there may be glomerulosclerosis which is 
characterized by glomerular basement membrane thickening. 
As a result, this causes diabetic glomerulosclerosis of the 
nodular or diffuse varieties of arterial and arteriolar 
nephrosclerotic pyelonephrytis. The first clinical pictures 
are porteinuria, edema, azotemia, and also hypertension. The 
first sign of nephropathy is edema. There is a possibility 
of silent myocardial infarction, papillary necrosis, and 
infections. (61). 
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In general, the management of diabetes is the balance 
between diet, exercise and ther~py. The diet in insulin-
independent diabetes is the keystone. Diet is considered 
the first step to control diabetes in obese patients. If 
the patient reduces his weight and the blood sugar is not 
controlled, other treatments must be initiated. When the 
symptoms of the disease are adequately controlled by reduc-
---·-·-tn-g-wc:ri-gn-t-an-d--the----regunrtron.·-<Yf-the-diet--;-··-no Otlfer -tne-rapy ______ - ---
is indicated, but if the obese patient cannot control his 
weight, then oral hypoglycemic agents or probably insulin 
is required. The diet adjustment must depend on several 
variables which include the kind and amount of physical 
activities, occupation activity, body weight, race, and 
other factors. The diet is calculated on the amount of 
calories required. A maintenance diet is calculated by 
multiplying the patient's weight in kilograms by 30, a reduc-
ing diet is calculated by multiplying the body weight in 
kilograms by 20 which will give the ·daily caloric intake. 
The ideal diet is composed of 40% carbohydrates, 20% 
protein, and 20% fat. These percentages need to be modi-
fied upon if there is liver disease, renal disease, and 
excess body weight. The daily food intake should be divided 
into five or more meals instead of three meals. Also, the 
intake of unsaturated fats should be reduced. A vitamin 
supplement is required, especially in older people and for 
those consuming a malnutritional diet (62). 
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The second step of management, if diet alone does not 
control the blood sugar level, is the use of oral hypogly-
cemic agent. These agents are the sulfonylureas. They act 
as stimulants to release insulin from the pancreas, and 
also they may enhance the effectiveness of insulin at the 
receptor sites. They also increase the affinity of insulin 
for the receptor site. Sulfonylureas are used in adult 
--------------,o~n"'s~e=t-diabetes .--Thoseagents wfli-cli afe--usuaTiy- use-d-are----------
listed in the following table (63). 
Oral hypoglycemics have an advantage in that they are 
easy to use, and also they are good for the non-insulin 
dependent patient, and they stimulate the release of endoge-
nous insulin. The disadvantage is dependence upon the 
patient to monitor himself when using these agents. There 
may be some adverse reactions. 
The first adverse reaction is hypoglycemia. This is a 
clinical conditon associated with a low level of glucose in 
the blood. During hypoglycemia the glucose blood level is 
less than 50mgjl00ml. The symptoms and signs of hypoglycemia 
are feelings of fatigue, heaviness, a tremor in the hands, 
confusion, nervousness, and sometimes delusions. The usual 
causes of hypoglycemia are due to: 
a) dietary changes or inadequate nutrition 
b) weight reduction, and the same time using the 
same doses of oral hypoglycemic. 
c) increasing physical activity above the normal 
level 
TABLETS OR PHARMAC~LOGICAL 
AGENT DURATION DOSE FREQUENCY .CAPSULES COMMEjNTS COMMENTS 
I 
Tolbutamide 8 hours 1000- 2 x a day 500 mg . .I drug of choice 1.nac t1.1ve 
(Orinase) 3000 mg or metabollic 






12-24 hrs. 500-1500 
I 
Acetohexamide once da:Uy 250 mg and metabo'lic pro- the second choice 
(Dyroelor) or 2 x a 500 mg d .I or alternative mg uct I.S more 







16-24 hrs. 100-1000 100-250 mg 
I 
Tolazamide once daily has 6 inetabo- intermediate 
(Tolinase) mg or 2 x a lite p!roducts duration of 




Chlorpropamide 24-36 hrs 125-500 once daily 100-250 mg excretion avoid in renal 







d) removal of stress, emotional stress or the stress 
due to a surgical operation 
e) termination of a pregnancy 
f) correction of hyperendocrinopathy such as Cushing 
Syndrome 
g) omission of meals, or forgetting to take a meal. 
There are many factors associated with hypoglycemia 
----------au~o orarll.ypog-rycemrc- agerfts-.--Tnese-factors -rncl uae Tna-p---------- · 
propriate dosage, a person uses more of the medication than 
is required, impaired renal functions leading to a prolonged 
hypoglycemic effect, or by administration of other drugs, 
which exacerbate the hypogly~emic effects. Also, if the 
hypoglycemia appears, sometimes syrups, juice, or milk may 
reverse the situation. The patient may require intravenous 
hypertonic glucose solution for severe hypoglycemia (58). 
There are many drugs which interact with the oral 
hypoglycemic agents. There are those drugs which may increase 
the effect and drugs which may reduce the effect leading to 
hyperglycemia. Anabolic steroids alone may decrease blood 
glucose level in some diabetes patients. It increases the 
hypoglycemic response to tolbutamide. Chloramphenical 
inhibits hepatic microsomal enzymes activity, the result is 
an increase in the half life of oral hypoglycemic agents and 
an i~crease in the activity of the hypoglycemic effect. Also, 
monoamine oxidase inhibition interferes with compensatory 
adrenergic response to hypoglycemic agents. It enhances or 
prolongs the hypoglycemic response. Phenylbutazone prolongs 
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the half life of the active metabolite of chlorpropamide and 
enhances the hypoglycemic response. Probenicid will inhibit 
the renal tubular secretion of chlorpropamide and enhances 
the hypoglycemic effect. 
On the other hand, alcohol, salicylates, thiazide 
diuretics, glucagon, epinephrine, and oral contraceptives 
antagonize the effect of hypoglycemic agents indirectly and 
may cause liyperglycemia-:-_______ --- ----------------- ----------- -----------
Instructions to the Pharmacist 
1. Oral agents should not be given until the patient knows 
how to balance a diet and exercise, and after the failure 
of the diet alone. 
2. Oral agents are contraindicated in a history of keto-
acidosis and insulin dependent cases. Also it is contra-
indicated with oral contraceptives. 
3. The patient who is sensitive to sulfa drugs may be 
allergic to sulfonylureas. 
4. Hypoglycemic side effects of oral agents are rare, but 
it may happen. 
5. If oral hypoglycemic agents and the diet combination 
fails, the next step is insulin therapy. 
6. Alcohol and oral hypoglycemic agents are contraindicated 
because alcohol and oral agents produce an antibuse-
like reaction. 
7. Alcohol increases the glucose level and causes hyper-
glycemia. It decreases the effect of the oral hypo-
glycemic agents (63). 
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Instructions to the Patient 
1. Your medication will not work if you exceed your recom-
mended diet by eating too much starch or carbohydrates. 
2. You must completely avoid table sugar, dates, and candy. 
3. If you take rich foods (nutritional food) you do not 
need to take vitamins unless your doctor recommends 
____________ i_t_. ----------------------- --------------
4. Salt should not be restricted from your diet except 
for other conditions which need salt restriction. 
5. Remember the fact that your diet should contain protein, 
fat, and carbohydrates· (a complete nutritional diet). 
6. It is recommended to eat on a regular schedule. Make 
.a table of times and follow the schedule carefully. 
7. Do not hinder your social life by refusing invitations 
to parties or dinners; go, but remember that.you must 
choose the foods which are good for you. 
8. To be safe, follow the diet strictly at all times. 
9. If you are doing more exercise, it is recommended to 
eat more snacks. 
10. Remember that oral hypoglycemic agents may have adverse 
reactions, and if this happens see your doctor. 
12. Take care and clean your feet, and do not wear tight 
shoes; be careful of your feet and protect them from 
injury or infections. 
13. Visit your opthamologist regularly to take care of your 
eyes. 
14. Remember that you must continue to take your medication, 







Hypertension occurs when the diastolic arterial blood 
pressure rises above 105mmHg. Age, sex, race, and environ-
ment are important factors in the etiology of hypertension. 
The mortality can be reduced by adequate therapy. It is a 
chronic disease that requires treatment all of the patient's 
life. There is no known cure for this disease. 
There are many factors associated with the increase in 
risk, as well as being considered precipitating causes for 
hypertension, such as age, obesity, smoking, high choles-
terol levels, and race. The cause of essential hypertension 
is unknown; but the family history and race play a role in 
this disease (65). 
The signs and symptoms of hypertension vary from one 
person to another. There may be no overt symptoms and the 
disease may be identified only by physical examination. 
Other patients may have symptoms which indicate an elevation 
of blood pressure, hypertension vascular disease or under-
lying diseases. The symptoms may include headache (espe-
cially in the occipital region), dizziness, palpitation, 
and fatigue. Also, there are symptoms related to vascular 
disease which include epistaxis, hematurea, blurred vision, 
angina pectoris, and dyspnea. If untreated it may lead to 
heart failure, polyuria, polydipsia, and muscle weakness 
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which are secondary to hypokalemea. 
The diagnosis depends on the symptoms seen, the blood 
pressure and the laboratory tests which include: a urine 
test for protein, a blood test for glucose, hematocrite serum 
potassium, serum createnine, blood urea nitrogen, and an 
electrocardiogram test for irregularities. 
The goal of treatment of hypertension is to maintain 
________ b_l_o_o_d-pr-es-sur-e-in_t_h_e_n_o-rm-al-r-ange- level- and-to- aec-::rease -t:ne-- -----
mortality associated with rising pressure (65). The first 
general method of treatment is weight reduction. It is very 
important to reduce the weight because it is a major risk 
factor (66). The second step is sodium restriction. The 
amount of sodium chloride ingested must not exceed 4-6gm. 
per day. The third step is improving the physical condition, 
especially by isometric exercises such as running. The 
physical activity will both reduce body weight and lower the 
blood pressure (65). The fourth step is removing the physio-
logical stresses and remembering that tension and anxiety 
will only raise the blood pressure (66). 
After all of the above, drug treatment is the next 
step. The therapy is usually begun with diuretics. The 
drug therapy is very important because the anti-hypertensive 
affect reduces the risk of hypertension complications, such 
as congestive heart failure, stroke, and renal damage (67). 
The complications of untreated hypertension are numerous, 
but the most important of them is hypertension enceph-
alopathy. The clinical picture is headache, nausea, mental 
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confusion, stupor, convulsions, and death if it is not 
treated. There may also be edema and thrombi in the brain 
if this condition is not treated. Hypertension can be 
complicated by hemorrhageic stroke, cerebrovascular insuf-
fi~iency, and acute left ventricular failure (66). 
It is important to begin treatment early to manage high 
blood pressure. The first step is the use of diuretics. 
-------n-i uret-ics are used-in-miTd~-rnode-rate-; anaseve:6~-liype:flen..::---------
sion. Sometimes the diuretics and salt restriction is enough 
for some patients. Diuretics produce a negative salt and 
water balance by preventing sodium retention. Since the 
anti-hypertensive effect of diuretics depends on adequate 
natriuresis, the effect could be reduced or abolished by 
excessive sodium intake, or by reducing the glomerular fil-
tration. Diuretics are of different types, classified by 
the site they effect: the filtration diuretics, such_as 
cardiac glycosides, proximal tubular diuretics, such as 
osmotic agents, and carbonic anhydrase inhibitors. A loop 
diuretic such as furosemide prevents the reabsorption of 
sodium. Aldacton (spironolactone) acts directly on the 
sodium pump and decreases aldosterone production. Thiazide 
has a diuretic effect and inhibits sodium reabsorption 
causing saluresis, which produces hyponatremia. Thiazides 
decrease calcium clearance, causing hypercalcemia, and 
decrease uric acid clearance, causing hyperuricemia. Thia-
zide also decreases creatinine clearance which causes 
azotemia. Also thiazide causes hypokalemea as well which 
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leads to hyperglycemea. Aldactone, a potassium sparing agent, 
does not produce the above side effects, but may cause 
amenorrheia in women and may cause gynecomastia in men. 
Thiazide diuretics should not be used in renal func-
tion impairment and the drug of choice is furosemide (Lasix). 
It is a potent diuretic which blocks chloride reabsorption 
in the ascending limb of the loop of the Henal in the patient 
w rtn renal-fa 11 ur e ( 6T)-. -----~------~ - ~----- -- --- -- --- ----~ -- -- -~ ~-~-~--- ---------~-~--~--~ 
The second step involves beta-blocking agents such as 
propranol (Inderal). Some claim that propranol can be used 
as the first drug, but the combination of diuretics and 
beta-blockers just is more effective. Propranol will 
inhibit renin activity and reduces cardic output. Beta-
blocking agents such as propranol are contraindicated in 
person with asthma. Also, beta-blockers must never be given 
to a patient without first ascertaining that there is no 
tendency for heart failure, or second degree heart block (68). 
The second step includes the sympatholytic agents (sympa-
thetic depressants) such as methyldopa (Aldomet) which forms 
false transmitter a-methyl noradrenaline and causes some 
depletion of axonal stores of noradrenaline and has some 
adrenergic neuron.e blocking action. Major side effects of 
methyldopa are fever, a positive Coombe test, and also may 
induce hepatotoxicity (hepatitis) and rarely hemolytic 
anemia. The adverse effects of methyldopa are sedation, 
fatigue, dry mouth, and salt and water retention, and sexual 
dysfunction (67). 
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Another drug is reserpine. It depletes the catechola-
mines and serotonin. It causes peptic ulcer, depression, 
nasal congestion, and possibly breast cancer (70). 
Clonidine (sympathetic inhibitor) reduces sympathetic 
outflow by stimulating a-adrenoreceptors. Adverse reactions 
to this drug are sedation, dry mouth, salt and water reten-
tion, sexual dysfunction, bradycardia, heart block and with-
which depletes axonal stores of noradrenaline and prevents 
storage and release of catecholamines. It has adverse 
reactions such as orthostatic hypotension, sexual dysfunction, 
diarrhea, salt and water retention, and intestinal cramping. 
Step three is arteriolar vasodilation. The vasodilators 
which are used are hydralazine, prazosin, diazoxide and 
nitroprusside. Hydralazine reduces blood pressure through 
direct relaxation of arteriolar smooth muscle. Adverse 
effects of hydralazine are related to the reflex sympathetic 
stimulation or its direct vasodilation. These include 
headache, flushing, nasal congestion and dizziness. 
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Instructions to the Pharmacist 
1. Diuretics must be given in.an adequate and standard 
dose to achieve the effect. 
2. It is not used if the glumorulor filtration rate is 
less than 35 ml. 
3. If there is no response to diuretics there are two 
_possible reasons wh_y not_:_____ _ ______________ _ 
a) vasoconstrictive type hypertension rather than 
volume dependent 
b) the diuretic does not induce adequate sodium 
diureses. 
4. Diuretic therapy may cause hypokalemia. The patient may 
need a potassium supplement. The pharmacist should 
advise the patient to take food rich in potassium. 
5. If the patient is taking aldactone, no potassium sup-
-plement is needed, because it is potassium sparing (68). 
6. Restriction of sodium is important because excessive, 
sodium intake renders the effect of diuretics useless. 
7. Thiazide causes hyperglycemia. It may be due to inhi-
bition of insulin or due to hypokalemia. The patient 
who takes oral hypoglycemic with thiazide should be 
monitored carefully. 
8. Thiazide interferes with many blood tests such as uric 
acid, amylase, blood ammonia. 
9. Thiazide may cause hypokalemia if the patient also takes 
digitalis; the possibility of digitalis toxicity may be 
enhanced ( 69) . 
10. Inderal iB- contraindicated-in asthma because inderal 
has brohchoconstriction and aggrevates the asthma. 
11. There are drug interactions between inderal and amino-
phylline. 
12. Antacids such as sluminum hydroxide inhibit absorption 
of inderal. 
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Instructions to the Pharmacists (continued) 
13. Digitalis and inderal may aggravate each other, and 
produce bradycardia. 
14. Barbiturates and phenytoin induce microsomal enzymes 
and enhance the metabolism of inderal. 
15. Phenytoin and inderal may increase the effect (synergis 
effect) and may depress the myocardium. 
16. A combination of two drugs with the same class and the 
same mechanism may aggravate the side effects and 
there will be no significant effect, for example, 
guanethidine plus reserpine. 
17. Tricyclic interferes with the guanethidine effect by 
blocking its uptake to adrenergic neurons. 
18. Anesthesia, procainamide, quinidine, or inderal exag-





Instructions to the Patient (68, 69, 70) 
1. Continue your medication and do not miss any day. 
Report any side effects to your physician. 
2. Drug therapy can make a difference and that can save 
your life. 
3. Remember there is no ideal drug for hypertension. Each 
one may produce sid~E3JJ~Q_t§l. __ RE:lPQI'_t_th_e_se __ t_o -~our _____ _ 
--doctor.-------------
4. Diuretics increase the excretion of sodium, so sodium 
intake must be restricted. 
5. You must eat food rich in potassium as diuretics will 
decrease your potassium level. 
6. If there is reserpine in your medication it may cause 
peptic ulcer. Do not exceed the dose which is recom-
mended to you. 
7. Remember that taking of clonidine should not be dis-
continued suddenly, as it can cause a withdrawal 
syndrome. 
8. The first dose of prazosin may cause syncope. This 
is an episode of sudden collapse and unconsciousness 
which can occur in the patient taking 2 mg or more 
for the first time. 
9. Begin a quiet life far away from those factors which 
aggravate your problem. Stop smoking if you do, and 
reduce your weight if you are overweight. 
Chapter 10 
GRAND MAL EPILEPSY 
Epilepsy itself is not considered a disease. It is a 
sign of other diseases or an alteration of physiological 
reactions of the central nervous system function. The sei-
----- ------ ----------- --------- ---- --- -- - -- ----- ----- ---------------------- --
zure is considered a sudden change of the central nervous 
system due to a paroxysmal high frequency or synchronous low 
frequency, or a high voltage electrical discharge. 
The signs and symptoms of seizures depends on how the 
seizure originated or which region of the brain is involved. 
The seizure by conduction mechanism spreads to the brain-stem 
center which controls the spinal motor neurons, then moves 
to involve all of the brain. The autonomic system is 
involved as well and th~ influence of this system in the 
body appears such as dilation of pupil~, salivation, etc. 
After seizures continue, the tonic muscular activity changes 
or progresses to clonic movement. Then the patient falls 
into a coma, followed by confusion and lethargy eventually 
returning to a normal state slowly (71). 
Grand mal epilepsy is characterized by four phases. 
The first phase is the prodomal phase; this is the aura 
phase in which the patient is aware of remembering past 
experiences, strange visual sensations, migraine headache, 
crying, and seeing or pointing to something. The second 
phase is the tonic phase. This phase is characterized by 
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muscle rigidity, and the airway is closed off by the vocal 
cord causing an epileptic cry. The third phase is the 
clonic phase. The convulsion is generalized with a tonic-
clonic spasm of. the extremities. The last phase is the ' 
postictal or relaxation phase in which the patient may 
sleep several hours and wake up with a headache, and some-
times a sore tongue. And, also the patient may have urinated 
1n-:nls cio'Clies~-nfs51adaer-having emptied during the seizure 
or during sleep. Due to the stimulation of the autonomic 
nervous system the patient is bathed in sweat, the pupils 
of the eye ~re constricted, and there is salivation and 
foaming of the mouth accompanied by respiratory difficulties 
(71, 72). 
The causes of epilepsy, in a general statement, is 
idiopathic, but there are some suggestions of causes leading 
to the convulsions. Some are severe perinatal injury 
(especially in the newborn). Metabolic defects such as 
acidosis, alkalosis, congenital malformations, infections, 
genetic disease, myoclonic syndrome, postnatal trauma, 
brain tumor, vascular diseases, and myclonus epilepsy. 
There is no clear proof that epilepsy is inherited, but the 
evidence for inheritance is strong if the patient's seizures 
start at an early age (71). Diagnosis of epilepsy depends 
on clinical manifestations, family history, signs and 
symptoms, an EEG to determine if there is a brain tumor, 
a spinal puncture to study spinal fluid, and brain scan to 




What to do for the patient who is in a convulsive 
state: 
1. Put the patient in a wide place and away from hard 
objects; put the patient in bed, or prevent the 
patient from falling down. 
2. Put something in his mouth such as clothes, or a 
hard thing between his jaws to prevent him from 
biting his tongue. 
3. Put the patient on his side, and avoid putting the 
patient on his back or on his abdomen because 
----------------tnere-i-s-a-ch-ance-c}f-v-omi_t_i_trg-~--- ------- ------------------------------
4. Loosen his clothing to avoid choking. 
5. Do not give the patient his medication orally and 
do not give him water or food . 
. 6. Check the breathing. If the breathing has stopped, 
give him artificial respir~tion. 
7. Watch carefully and call an ambulance. 
Grand mal epilepsy have regular intervals but the inter-
val may be close enough that they occur more than once in 
24 hours. Status epilepticus needs emergency treatment and 
medication by intravenous route is necessary for treatment. 
The treatment goal is complete suppression of the 
seizures, at a dose level which will produce this effect 
without signs and symptoms of drug side effects or toxicity. 
The drugs that are commonly used to treat grand mal epilepsy 
include phenytoin (which is the drug of choice). Pheno-
barbital, primidone and carbamazepine are the alternatives. 
Also, there are combinations of these drugs. In the follow~ 
ing tables the drugs commonly used with some of their 
respective characteristics are listed (73). 
Drugs that are used in the treatment of Grand Mal Epilepsy (73j 
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When the patient is in status epilepticus, the intra-
venous route is used. Intravenous diazepam is the drug of 
choice often but sometimes phenytoin is preferred. Phenytoin 
has brand names such as dilantin, dilabid, ditiycon, and 
dilan. It has been used for forty years and still is the 
most popular drug to treat grand mal epilepsy. Ninety percent 
(90%) of this drug is bound to protein and is metabolized in 
the steady state is reached in four to five days. It has 
side effects such as ataxia, diplopia, vomiting, and hyper-
sensitivity reactions such as skin rashes and fever. Also, 
phenytoin may produce liver dysfunction, such as hepatitis. 
Also, chronic use may produce hypertrophy of the gums. It 
causes folic acid deficiency with or without microcytic 
anemia. Also it interferes with Vitamin D metabolism with 
thyroid functions. It will also cause nystagmus (74, 75). 
At blood level greater than 30 mgjml ataxia and dysarthria 
can occur. Additionally, Vitamin K level may be depressed 
and bleeding disorders have been reported. Phenytoin is 
teratogenic which may cause congenital abnormalities (75). 
Phenytoin has an affect on membrane cell stabilization. 
It will stabilize the exciting membrane and prevent the 
spread of the seizures. It will reduce sodium and calcium 
influx into the nerves and prevent post-tetanic potentiation 
and post-tetanic hyperpolarization, as well as decreasing 
the neurotransmitter from the nerve endings (77). 
123 
The second drug is phenobarbital. Phenobarbital is 
used as an alternative to phenytoin, and it is a widely used 
and effective drug. It may be used in combination with 
phenytoin and carbamazepine. The side effects of pheno-
-~ ~ 
<=j 
barbital, or the unwanted effects, are sedation, nystagmus, 
ataxia, and osteomalacia. Also in young children, hyper-
activity or restlessness may occur. Addiction to phenobar-
ability (76). 
Phenobarbital is a potent anticonvulsant, more so than 
other barbiturates. There are some qualitative similarities 
with phenytoin. They block the sodium conduction, stabilize 
the nerves, and decrease calcium influx into the depolarized 
nerve endings. It will depress the sympathetic transmission 
at a number of different sites (71). 
The third drug is primidone (mysoline) and it is also 
effective in grand mal epilepsy. It is absorbed quickly. 
The half life is about 12 hours. It is converted to two 
active metabolites, which are phenobarbital and phenyl 
ethylamalonamide. The sdie effects include ataxia, nausea, 
and irritability in children. It is absorbed from the 
stomach and the intestines and most of its effect is due to 
its metabolite phenobarbital. The most common side effect 
is drowsiness and the mechanism of action is similar to 
phenobarbital (76). 
Finally, carbamezepine (Tegretol). It is useful in 
the treatment of generalized tonic-clonic seizures, but more 
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effective especially in the treatment of partial seizure. 
The drug has side effects including dizziness, ataxia, diplo-
pia, drowsiness, impaired hepatic function, and bone marrow 
suppression. It is structurally related to the tricyclic 
antidepressants (76), but its major effect is as an anti-
convulsant. The adverse effects include hepatitis, aplastic 
anemia, heart block, ataxia, diplopia, and skin rash. 
-------------I-t-i-s-vel'-y-impe-r"b-a-nt--to-know-the- drug- intera-ctions-with------- --
anticonvulsants. The drugs which are used in grand mal epi-
lepsy are phenytoin, primidone, phenobarbital, and carbamaze-
pine. In g~neral, tricyclics may produce epileptic-form 
seizures in susceptible patients and the patient must be moni-
tored closely. Also, oral contraceptives induce fluid reten-
tion and may precipitate seizures. It is recommended that 
epileptic patients use another birth control rather than an 
oral contraceptive. It is important to know this information 
about phenytoin drug interactions, and also the complications 
·of treatment and overdoses, and how to treat it (71, 78). 
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Instructions to the Pharmacist 
1. · Patients with epilepsy and glaucoma using acetazolamide 
will have increased side effects of the anticonvulsant, 
and osteomalacia may be induced. 
2. Alcohol enhances the metabolism of phenytoin and seizure 
control is reduced. 
3. Antihistamine preparations enhance the phenytoin plasma 
_________ leY-el_and--mRy-inc!'-ease -toxici-ty. ----- --- -- ---- -- -- -----
4. Barbiturates induce microsomal enzymes and increase the 
metabolism of phenytoin and the serum therapeutic level 
is decreased. 
5. Benzodiazopines increase the blood level of phenytoin. 
6. Phenytoin enhances the metabolism of corticosteroids. 
7. Diazoxide enhances phenytoin metabolism. 
8. Phenytoin enhances the metabolism of digitalis. 
9. Folic acid, when given, will decrease the phenytoin level 
in the blood and phenytoin will also cause folic acid 
deficiency. 
10. In general, the basic drug interactions are due to altera-
tion of absorption, interference with protein binding, 
or with the metabolism. 
11. Acetazolamide reduces the gastrointestinal absorption of 
primidone. 
12. Primidone is converted to two metabolites. Gving bar-
biturates plus metabolites will increase the blood level. 
13. Propoxyphene inhibits the metabolism of carbamazepine. 
14. Barbiturates stimulate the metabolism of carbamazepine. 
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Instructions to the Patient 
1. Do not treat yourself by the ways or methods the public 
describes to you. 
2. The treatments which are used in the hospital are the 
ideal method for your problem. 
3 . __ _ Dg_ not_di_s_c_Qn_t_inue_ the _treatment for any --reason and- be- --
careful not to take an overdose. 
4. Refill .your prescription before your medication is 
finished and visit your physician regularly. Report 
any side effects to your physician. · 
5. It is recommended to avoid driving a public vehicle 
or work with sharp or dangerous machines. 
6. Do not travel without enough medication. 
7. It is recommended when traveling that you take with you· 
your certificate which shows that you are using the 
medication legally. 
8. If you have an illness other than epilepsy and you need 
to take another drug, tell your physician about your 
medication to avoid drug interactions, or an alteration 
of the serum level of your medication. 
9. Remember that you are not alone in this world, but 
there are millions of people you you who have epilepsy 
(73, 75, 78). 
Chapter 11 
GLAUCOMA 
Glaucoma is most common in older people and is a very 
I 
complicated disease which needs very careful management. 
Glaucoma is a chronic disease with multiple etiological 
causes. Sometimes glaucoma is asymptomatic and causes irre-
versible destruction of the visual field. The treatment is 
very important to prevent progression of the disease and 
hence, loss of' vision. It should be detected early to begin 
treatment, and the patient must continue using the medication 
all of his life (79). 
The definition of glaucoma is a rise in the intraocular 
pressure of the eye. Normally there is a constant production 
of clear fluid within the front part of the eye, which is 
drained away as fast as it is produced. In glaucoma, there 
is interference with the drainage of this fluid which leads 
to increased pressure. Thus, in glaucoma, there is an increase 
in the intraocular pressure which leads to a change in the 
optic disk and gradually a loss of the visual field. This 
increases the intraocular pressure due to obstruction to the 
outflow of the aqueous humor. The aqueous humor is produced 
primarily in the cilinary body with drainage from the posterior 
chamber via the pupil into the anterior chamber of the eye. 
It discharges from the eye through the canal, called Schlemm, 
at the angle of the eye, to the veins (80). 
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In the following table are listed the types and kinds of 
glaucoma. This classification divides glaucoma into four 
categories depending on the causes and characterizations of 
each type. 
I. Primary Glaucoma 
1) Open angle glaucoma 
2) low tension glaucoma 
3) Primary closed angle glaucoma 
II. Variants of Primary Glaucoma 
--~-~- -- -~-~- -------1-)--P±gmentary~glaucoma 
2) Foliation glaucoma 
III. Devlopmental Glaucoma 
1) Primary 
2) Infantile 
3) Glaucoma ·associated with heredity 
IV. Secondary Glaucoma 
1) Inflammatory glaucoma 
1. Ureitis of types 
2) Phacogenic glaucoma 
1. Angle closure with cataract 
2. Phacoanophylactic glaucoma with rupture 
of the lens 
3) Glaucoma secondary to intraocular hemorrhages 
1. Hypqema 
2. Hemolytic glaucoma 
4) Traumatic glaucoma 
1. Traumatic recession of chamber 
2. Post-surgical glaucoma 
5) Drug induced glaucoma 
1. Corticosteroids 
2. Anticholinergic 
6) Miscellaneous glaucoma 
1. Tumor 
2. Chemical burns 
3. Irish ·atrophy 
The symptoms of glaucoma are various. If the patient has 
open angle glaucoma, there are no symptoms (Silent). The 
disease progresses slowly. It may become advanced before the 
patient recognizes it, but some indications such as the need 




glaucoma. The second type which is characterized by severe 
headache, pain, nausea, vomiting, and decreased visual activity, 
halo and rainbow vision is an indication of closed angle 
glaucoma (79, 80). 
If the patient does not have glaucoma treated, the chronic 
elevation of intraocular pressure will effect the nerve fibers 
by influencing the vessels which supply the nerve fibers. 
---------------I-nc-r-ea-s-i-n-g--t-he--p-F-essure--\V-i-11---cause ischemic -impairmen-t-- and--
reduce the nutrition supply, impair axoplasmic flow (proto-
plasm of the axon) and hence, gradual and irreversible destruc-
tion, leading to blindness. The greater the rise in intraocular 
pressure, the more serious the complications (79, 80). 
There are three factors which influence the pressure:: 
the rate of aqueous production, the rate of aqueous outflow, 
and the volume of other tissues within the eye. There is 
equilibrium under normal pressure but with glaucoma there is 
no equilibrium. The normal intraocular pressure is 12 to 
21 mmHg. The visual field diminishes. within five years in 
3.5 percent of patients with intraocular pressure between 
21 and 30 mmHg. The more the ocular pressure increases, the 
greater the risk for loss of vision (79). 
The goal of the treatment of glaucoma is to reduce and 
sustain the intraocular pressure in order to prevent deterioa-
tion of the optic nerve and loss of visual function. The 
drugs which are used are divided on the basis of mechanism of 
action. Some drugs cause an increase in the elimination of 
aqueous humor; others decrease the production of aqueous 
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humor. The basis of treatment of glaucoma is: 
A. Increasing elimination of aqueous humor by a drainage 
system. Such drugs are parasympathomimetics and 
sympathomimetics. 
B. Drugs which decrease the formation of aqueous humor 
by the ciliary process. Those drugs are sympatho-
mimetics and carbonic.anhydrase inhibitors. 
------------------------G-.-- -'r-he-r-e--a-re--d-rugs--wh-ich -reduce---t-he- ... vo-lume- of --aqueou-s---------------
humor in the anterior chamber. Those drugs are 
hyperosmotics, such as mannitol. 
The drug therapy is to manage open angle glaucoma, but it 
is necessary to use surgery for closed angle glaucoma (81). 
The drugs which influence the outflow and increase the elimi-
nation of aqueous humor are parasympathomimetic drugs which 
include direct acting cholingergics such as pilocarpine and 
carbachol. Also cholingeric Bsterase inhibitors such as 
physostigmine (Eserine) and sympathomimetic agents such as 
epinephrine. Sometimes beta andrenergic blocking agents are 
used such as Timoptic. There are drugs which reduce the over-
production of aqueous humor, which are sympathetic, such as 
epinephrine and carbonic anhydrase inhibitors, and Diamox 
(acetazolamide). Also, hyperosmotic agents, such as mannitol, 
are given intravenously (32). 
The medications are used essentially to treat open angle 
glaucoma. The medications are eye drops such as pilocarpine, 
epinephrine, anticholingeric esterase, echothiophate iodine 
drops, and demecarium bromide. Also, systemic medication 
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such as carbonic anhydrase inhibitors, e.g. Diamox (80). 
The first line of treatment is a parasympathomimetic, 
pilocarpine, for example, which have direct cholingeric effect. 
Pilocarpine is considered the drug of choice. It will increase 
the elimination of aqueous humor, and induce miosis. Pilo-
carpine causes contraction of the ciliary muscles and dilation 
of the aqueous veins into which the schlemm canal empties. 
'l'he-o~f-ie-ia-1-preparations -are pilocarpine chloride-, and pilo-- ----
carpine nitrate. They are available in opthalmic drops and 
ointment. The side effects and toxicity of pilocarpine are 
due to the toxicity of the parasympathomimetic activity which 
is treated with atropine (83). Those drugs which include 
pilocarpine and carbachol are called miotic agents (84). The 
other types from this class are cholinesterase inhibitors which 
have miotic effect but are rarely used. The following table 
shows the characterizations of the two most important agents 






Direct-Acting Cholinergic Drugs 
PILOCARPINE 





instill 2 drops 
four to six times 
in eye daily 
CARBACHOL 





one drop two to 
three times daily 
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Increases the rate of elimination of 
outflow of aqueous humor (for both) 
Conjunctival, congestion, irritation, 
myopia, and poor night vision (for both) 
__ §y~t-~mig_~:i._<!_e __________ Na._u$ea, diarrhea, _bradycardia,_ and 















(79, 82, 84, 85). 
There are also other agents from this group which increases 
the rate outflow. These are cholinesterase inhibitors such as 
eserine, (Physostigmine), neostigmine demecarium, echothophate 
iodide. The following table lists the characteristics of 
those agents. This table is extracted form U.S. Pharmacist, i, 
April 1979 ( 82). 
Other drugs which increase the outflow are sympathetic 
amines such as epinephrine and phenylephrine. The epinephrine 
brand names are Adrenaline, Epifrin, and Epitrate. The solution 
concentration is 1%-2% and is applied twice or thrice daily. 
The other drug is phenylephrine for which the solutions concen-
tration is 10%. The sympathetic drugs will increase the outflow 
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and reduce the pressure of aqueous humor (82). 
The second class which reduces the rate of aqueous humor 
production consists of sympathetic and carbonic anhydrase 
inhibitors. Carbonic anhydrase inhibitors include several 
drugs, but the one most commonly used is acetazolamide (Dia-
mox). The usual adult dose is 250mg four times a day. The 
major side effects of Diamox are gastrointestinal distur-
hypokalemia, hyperuricemia, acidosis and kidney stones. 
Diamox is a mild diuretic which reduces the production of 
aqueous humor, not from the diuretic effect but by blocking 
the ocular carbonic anhydrase. Hyperosmotic agents such as 
mannitol, urea, glycerol, and isosorbid are used to reduce the 
ocular pressure by increasing the osmolality of the blood 
relative to the fluid of the eye. The result of that is that 
they create an osmotic gradient between the two compartments. 
The most common one used is mannitol·which is used at lgmjkg 
intravenously over 30 to 45 minutes. The major side effects 
are circulatory overload, edema, cellular dehydration, urinary 
retention and electrolyte imbalance. They are used especially 
in preoperative management of acute closed angle glaucome 
( 82' 83' 85). 
Dosage 












PHYSOSTIGMINE (ESERINE) . _NEOSTIGMINE DEMECARIUM BROMIDE 
'Ill· 
0.25% to 0.%, one drop 






Cholinesterase Inhibitors (all) 
Open Angle Glaucoma (all) 
5% solution, 
one to two drops 





Increases the rate of outflow of the aqueous humor 1(all) 
0.125% or 0.25%, 





Pupillary and accommodative spasm, twitching of the: eyelids, pigmentary 
changes in the iris, cataracts, conjunctival thick~:ning, refractive changes 
Nausea, diarrhea, bradycardia, sweating, and central nervous system 
excitation (79). (for all) ' 





Instructions to the Pharmacist 
1. There are many drugs which may induce glaucoma, or 
are contraindicated fo~ a patient with glaucoma. 
A. Nitroglycerin should not be used in a patient 
with glaucoma, because nitroglycerin which is 
used· in angina will increase intraocular pressure. 
B. Beta blocking agents such as inderal sometimes 
reduce intraocular pressure. 
C. Oral contraceptives may induce glaucoma. 
D. Corticosteroids will increase the intraocular 
pressure of the eye. 
E. There is a misconception that systemic anticholin-
gergics aggravates or induce open angle g~aucoma, 
but in a patient with abnormal narrow angle 
glaucoma this may be true. 
2. Therapy is started by using the smallest dose of 
pilocarpine that will control the pressure of the eyes 
and increase the dose if there is no, or an inadequate, 
response. If the patient is unable to tolerate 
pilocarpine, the alternative is carbachol. 
3. Epinephrine in some patients may be used to initiate 
therapy. 
4. A combination of drugs may be used depending on the 
response of the patient. 
5. Carbonic anhydrase inhibitors are available in two 
forms; normal form and sustained released. 
6. Combinations wh1ch are recommended are usually from 
a different class, and have a different mechanism. 
7. Monitor the patient closely. 





1. It is recommended that the person above 40 years of 
age should visit the physician and have a routine 
examination of his eyes, because there is a type of 
glaucoma which is asymptomatic (silent). 
2. Carefully follow the directions which your doctor 
recommended to you, and follow the treatment. Report 
_______________ a_!ly_§_id~_~ff~cts _ tQ you_r doc_tor_. _______ . 
3. Open angle glaucoma is considered a chronic disease 
and there is no cure for this kind of glaucoma. You 
must use your medication all of your life. 
4. If you have more than one kind of eye drops, it is 
recommended to give each drop the time to be absorbed 
by applying the first drops, and then waiting 10 to 
15 minutes before applying the other ones. 
5. Ask your pharmacist or your doctor about any medica-
tion which you use other than your eye drops. It 
may be contraindicated. 
6. Remember that if you do not use your medication as 
recommended the pressure of your eye will rise and 
could lead to blindness (82, 85, 86). 
CONCLUSION 
For the Pharmacist: It is also true that you are 
facing a lot of people every day and your time is limited, 
but try to be helpful in your field and your responsibility 
as a consultant about the medication. Be sure that you can 
give the patient the correct doses and the correct medica-
tion, and give'the patient the best instructions or advice.· 
Your good communication with the physician will increase the 
level of the job you are doing and the level of treatment. 
For the Patient: It is also too often true that a 
doctor, especially in an Outpatient Clinic in any hospital, 
has a limited amount of time to spend with you. Therefore, 
to spend the time wisely and to understand carefully the 
instructions from your doctor will help you increase the 
chance for your recovery. If you are confused or not sure, 
do not be shy, and do not be afraid-to ask again. Be 
cooperative with your physician and the pharmacist. All of 
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